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Carbon monoxide (CO), an odorless, tasteless, colorless, non­
irritating gas, is the most abundant and widely distributed air pollu­
tant found in the lower atmosphere (Goldsmith, et al., 1968). It is 
an active reducing agent for chemicals at elevated temperatures, but 
it is principally encountered as a by-product of incomplete combustion 
of carbonaceous material.
Carbon monoxide as a component of the ambient air, has existed 
ever since the geologic ages prior to Pleistocene (Encyclopaedia Bri­
tannica, 1969). As a gas CO was discovered by Priestly in 1799 (Bour, 
et al., 1967) and the composition of CO was first established by Cle­
ment and Desormes in 1801. The Greeks knew of the effects of CO, and 
the Romans used it for suicides and punishment of criminals (Cooper, 
1966).
Tliere was relatively high concentrations of atmospheric CO from 
natural sources such as vegetative and animal growth as well as volca­
nic activities before man learned to make fire. At present, emission
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of CO gas generally exceeds that of all other gaseous pollutants com­
bined. especially in urban and industrial atmospheres.
Carbon monoxide is one of the most frequent forms of poisoning, sec­
ond to only alcohol in the United States (Lilienthal, 1950a; Rose, 1969b).
The results of extensive studies show that in excess of 3.5 billion tons 
of CO per year are produced in the Northern Hemisphere from natural 
sources, primarily from the oxidation of methane produced in swamps and 
paddies and the degradation of chlorophyll from rotting plants (Maugh,
1972).
According to these estimations, there are 530 million tons of CO 
present in the atmosphere. Only 102 million tons of this amount is re­
leased into the atmosphere annually by man-made sources (Swinnerton, et 
al., 1970).
It is obvious that man contributes a small percentage of CO to
the atmosphere. The reports indicate that biological soil systems are
an active and efficient natural sink for CO (Inman, et al., 1971). In 
natural processes, the soil system in a geographical area the size of the 
continental United States, can remove approximately 570 million tons of 
CO per year; an amount more than six times the estimated annual produc­
tion of CO attributed to man's activities in America and over twice the 
worldwide production.
In 1968 it was estimated that 102 million tons of CO were released 
into the atmosphere by the major sources of emission (Air Quality Criteria 
for Carbon Monoxide, 1970). Over one-half of this quantity was produced 
by the gasoline-powered internal combustion engine. Specialized industrial 
processes accounted for approximately 10 percent of the total.
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Even though natural soil systems for the removal of a signifi­
cant amount of CO from the ambient atmosphere apparently exist» never­
theless, there is reason for concern. Industrialization with the dense 
population in the industrial centers and urbanization have increased 
tremendously. Many soil systems have been occupied and destroyed and 
can no longer act as active CO absorbers. At the same time, man-made 
CO emission has increased tremendously (Hoyt, 1967).
At the present time, emission of CO gas generally exceeds that 
of all other gaseous pollutants combined, especially in urban and in­
dustrial atmospheres. Large quantities of CO are emitted from petro­
leum refineries, iron foundries, kraft pulp mills, sintering mills, 
lampblack plants and formaldehyde manufacturers.
Major sources of CO production within the first three industries 
have been identified as arising from the cupola in the iron foundary, 
the catalytic cracking units in the petroleum refineries, the lime kilns, 
and the kraft recovery furnaces in the kraft paper mills. Besides all 
the major CO-producing industries, there are numerous operations such as 
automobile repair, traffic control, tunnel construction and arc welding, 
practices in which the occupational exposure to CO can be considerable.
In fact, any industrial process or operation in which incomplete com­
bustion of carbonaceous material is present may be of consequence as 
concerns occupational exposure to CO
Because of CO emission, this pollutant shows a pattern related 
to motor vehicle traffic flow. Also, the exposure to CO may vary by or­
ders of magnitude with the highest exposure occurring when riding in the
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car; thus setting up special dosage situations. Community sources seem 
to affect the background levels. There may be a relatively wider ex­
posure of the general population to CO as the levels become higher over 
a large area.
In addition, there may be problems of shorter term exposure to 
higher levels of CO in commuter traffic. Most exposure to CO occurs 
during the air pollution episodes when CO levels appear to rise above 
the acceptable standard levels.
In Los Angeles, New York, Washington and other large cities, 
most of the ambient CO is emitted by transportation activities which gen­
erally are the source of 70 to 90%+ of the emitted CO. The combustion of 
fuels for the heating of occupied buildings and generating heat and power 
for industry accounts for a substantial portion of the remaining emission* 
(Ott, e^ , 1967).
A Continuous Air Monitoring Program (CAMP) was begun in 1962, by 
the Division of Air Pollution to measure the concentrations of six gaseous 
pollutants, CO, NO, NOg, SOg, total hydrocarbons, and total oxidants in 
downtown areas of six cities: Chicago, Cincinnati, New Orleans, Phila­
delphia, San Francisco, and Washington. Concentrations for each of the 
six pollutants were obtained for 5-minute intervals. To obtain concen­
trations for longer time periods, all the available 5-minute values for 
the designated time period were averaged. In 1966, CO annual average con­
centrations measured at the CAMP sites in Chicago, had an arithmetic mean 
value of 12.5 ppm for the year.
A more meaningful measure is the frequency distribution of 8-hour 
concentrations. This has been done by members of National Air Pollution
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Control Administration. The maximum 8-hour average concentration mea­
sured for Chicago for the period of December 1, 1961, to December 1,
1967, was 44 ppm, and the minimum was zero. Concentrations of carbon 
monoxide which exceed 12 ppm for a period of 8 hours or more would tend 
to raise the carboxyhemoglobin level by 2%. Data are available for the 
other cities for differing time periods.
The levels of exposure to CO for commuters during rush hours 
were also determined. National Air Pollution Control Administration’s 
Division of Air Quality and Emission Studies found that during a half- 
hour trip, averages of CO were discovered to be in the 10-40 ppm range 
in the 15 cities, with short-term peaks as well over 100 ppm in the 
larger cities. The levels varied significantly by type of route also. 
Average over all 15 cities, trips confined to center cities showed 
levels of 31.5 ppm compared to 21.6 ppm on arterial streets leading to 
downtown and 21.1 ppm on expressways. These values changed noticeably 
during the air pollution buildup or episodes. The reports show that on 
November 24, in New York, the peak value was 35 ppm, whereas two days 
earlier, it was 8 ppm.
Most epidemiologic studies of CO health effects have dealt with 
occupationally exposed groups. The effects usually observed are in­
creased levels of carbon monoxide saturated hemoglobin, carboxyhemoglo­
bin (COHb), and the disputed "chronic carbon monoxide poisoning syndrome" 
(Sievers, 1942; Grut, 1959). Grut studied 721 men of whom 46% had chronic 
CO poisoning. This syndrome was characterized by fatigue, headaches, ir­
ritability, dizziness, and disturbed sleep. Some subjects were noted to
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have abnormal neurologic problems. Vehicle inspectors exposed daily to 
CO concentrations ranging from 10 to 150 ppm were studied. Differences 
in COHb levels between exposed and non-exposed groups were only signi­
ficant in nonsmokers, (Hofrenter, e^ ̂ . , 1962). Blood samples were also 
obtained from policemen and drivers in Rotterdam and Amsterdam before and 
after work. Increased COHb levels were demonstrated in these occupation­
ally exposed subjects. A control group exhibited no such increase (de 
Buim, 1967).
Studies to determine the levels of COHb in blood samples of 331 
traffic policemen in Paris showed that increase of COHb of nonsmokers and 
showed very little increase in COHb of smokers after a five hour work 
period. Cigarette smokers did not smoke while at work (Chovin, 1967).
The effects of CO as an air pollutant on human health have been 
pondered for years and much has been written about the amount of this gas 
discharge into the atmosphere and its potential effects on life. However, 
it was not until 1958, that attempts were made to test the hypothesis that 
during high periods of CO pollution, individuals hospitalized with acute 
cardiovascular disease were adversely affected in 35 Los Angeles County 
hospitals (Cohen, et ^ . , 1958). Three years later, Hechter compared air 
pollution with daily mortality and concluded that there was a possible 
correlation between daily highs and mortality and postulated that this was 
seasonal in nature (Hechter, et al., 1961).
The major concern in CO as an air pollutant are the additions of 
the automobile exhaust control legislation to the Clean Air Act by the 
89th Congress (Giever, 1967), the formation of the Laboratory of Medical
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and Biological Sciences in the Division of Air Pollution and the incep­
tion of the Fried Laboratory (Hueter, 1966a; Goldberg, et al., 1967b) 
which selected CO as the primary contaminant to be studied by behavioral 
methods.
Further evidence of the significance of chronic CO as a health 
hazard may be indicated by the action of the Committee of Threshold Li­
mits of the American Conference of Governmental Industrial Hygienists, 
which in 1964, recommended that the Threshold Limit Value (TLV) for CO 
in workroom air be lowered to 50 ppm by volume; from the figure of 100 
ppm which it had sustained for many years (Giever, 1967).
The California State Board of Public Health in 1959, adopted 
standards for ambient air quality, and stipulated as a "serious level"
30 ppm of CO for 8 hours or 120 ppm for 1 hour.
Cohen and his associates studied the effect of CO pollution in 
the Los Angeles Basin on case fatality rates of patients with myocardial 
infarction. These studies involved hospitals where it was found that 
there was an increased myocardial infarction-case-fatality-rate in areas 
of high levels of CO pollution (Cohen, 1969). By using a complicated 
mathematical model involving complex regression analysis, Hexter, et al., 
1971, found a statistical significance (p < .002) between CO levels and 
mortality in the Los Angeles Basin.
Most exposures to CO, other than the low levels involved with air 
pollution, are occupational and are under regulated and controllable situ­
ations (Air Quality Criteria of Carbon Monoxide, 1970). The most signifi­
cant exception to this is the exposure to low levels of CO for long periods
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of time, ranging from a month to a lifetime, and in the range of CO con­
centrations that would produce 0.5-10% COHb. Also, in the case of occu­
pational exposures to CO, a worker’s smoking habits must be taken into 
consideration (DuBois, 1969). This factor has not been generally con­
sidered until the past few years.
These recent reports raised many questions concerning the effects 
of low-level exposures to CO for a long period of time. The diversity of 
opinions and the conflicting experimental evidence existing in this area; 
does not permit the clear-cut assessment of the scientific merit of such 
data or its extra pollution to the normal working population. If reli­
able data became available which clearly demonstrated impairment of em­
ployees' health during exposure to very low levels of CO, then the criteria 
for the recommended standard would be reversed on the basis of the addi­
tional evidence.
There are clear evidences from the intensive studies that effects 
of exposure to the concentrations of CO found in cigarette smoke is much 
more hazardous to human life than had been realized in the past (Ringold, 
et al., 1962). A level of 5.9% COHb was found to be the median value in 
moderate cigarette smokers who inhale. Relatively low levels were found 
in pipe smokers who also inhaled. COHb levels by analysis of expired air 
were estimated for 299 post office workers and gave similar results (Gold­
smith, et al., 1963a; C o b u m , et al., 1965b; Lawther, 1971c; Cohen, et al., 
1971d).
Exposure for five hours to between 10 to 12 ppm of CO has been 
shown to increase the COHb levels in non-smokers by at least 0.5%. Such 
an increase adds appreciably to the body burden of COHb in those who do
not already have such a body burden from cigarette smoking. Longer ex­
posures could have produced a somewhat greater increase.
There are clear evidences from the intensive studies that the 
effect of exposure to the concentrations of CO found in cigarette smoke 
may be causing emphysema which is a disease occurring with increasing 
rapidity among heavy cigarette smokers. Emphysema and lung cancer have 
much in common as to cause change in the bronchial mucasal epithelium—  
surface cells of the air passages of the lungs (Von Cettingen, 1944).
Carbon monoxide in cigarette smoke produces arterial changes that help 
to cause damage to the air sac walls. This literature contains signifi­
cant scientific information on the pollutant gas (CO) relative to its 
effect on the hardening of the arteries (arteriosclerosis) and damaged 
heart muscle (Astrup, et , 1970a; Bartlett, 1968b). This leads to 
myocardial infarction which if extensive enough, causes death. The re­
ports as a whole reflect a consistent pattern, namely cigarette smoking 
imparts profound alterations in the human coronary system as a result of 
myocardial fiber hypoxia.
This particular air pollutant (CO) combines with significant quan­
tity of hemoglobin and myoglobin causing a reduction in operation effici­
ency. It is reasonable to assume that the compensatory mechanisms are not 
sufficiently sensitive to prevent damage to myocardial fibers or that there 
is not enough oxygen available to prevent the damage regardless of the a- 
mount of blood flow through the coronary system (Myasnikov, 1958).
These damages are usually reported on autopsies as myocardial ne­
crosis. In an average normal man (standard man, 70 kgm), myocardial tissue
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comprises 0.5 percent of the total body and consumes oxygen (Og) at the 
rate of 9.5-10 ml/100 gm/minats. Blood flows to the myocardium at the 
rate of 84 ml/100 gm/min. which is a rather small quantity in compari­
son with other organs (Ganong, et al., 1971a; Taylor, 1965b). Based on 
this comparison, it is evident that the myocardium needs the largest 
quantity of 0^ and expels greatest amounts of arteriovenous Og differ­
ence. The myocardium consumes 11.6 percent of the Og while that con­
sumed by the total body is only 4.7 percent of the total cardiac out-put.
The average smoker maintains a COHb saturation of 5 to 8 percent 
constant which later becomes critical in the circulation (Clayton, 1968a; 
Bartlette, 1968b). The body stores CO not only by combining it with 
hemoglobin, but also extravaacularly stores it bound to myoglobin. The 
cytochromes also catalyze it with the use of peroxidases. There is now 
increasing evidence that the myoglobin of heavy smokers may be saturated 
with carboxyhemoglobin (Coburn, et , 1963a; Cobum, 1970b). The po­
tential significance of this is that myoglobin is the mechanism for Og 
transport in the tissues and therefore the major source of oxygen for the 
myocardial tissue. Similar carboxyhemoglobin levels have been shown to 
intensify myocardial ischemia and to enhance development of arrhythmia 
during exercise in subjects older than 40 years (Krelson, 1972), indicat­
ing that coronary obliterations increase the susceptibility of carbon 
monoxide exposure (Gray, 1966).
Electrocardiographic changes are often found, but occasionally 
the electrocardiogram does not show any abnormality. The precipitating 
factors of coronary insufficiency pattern might be shock or right ventri­
cular dilatation.
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Some investigators suggest that adequate functioning of the 
heart increases the general risk in CO poisoning (Lewey, ^  al., 1944). 
Studies with dogs exposed to 100 ppm for eleven weeks, indicated that 
significant changes in (EKG) electrocardiographic pattem occurred.
Under hypoxic conditions increased oxygen supply to the peri­
pheral tissues can be accommodated by increased blood flow (via vascu­
lar dilatation)and increased oxygen extraction by the tissues. The my­
ocardium under these circumstances appears to increase flow of blood 
rather than to extract an additional amount of oxygen from the coronary 
circulation. While the peripheral tissues normally extract only 25 
percent of the oxygen content of perfusing arterial blood during rest­
ing conditions, the myocardium extracts 75 percent, thus leaving the 
mixed venous blood only 25 percent saturated (Jones, et , 1965).
This mechanism has the over-all effect of maintaining the myocardial 
oxygen tension at a higher level which would be present in other muscle 
tissue and thus increase a continual aerobic metabolism, even under hyp­
oxic duress. In terms of oxygen tension, the mixed venous blood of the 
peripheral tissues is approximately 40 mm Hg while the mixed venous 
blood of the coronary circulation is only 20 mm Hg. (In the presence of 
COHb, the oxyhemoglobin dissociation curve shifts to the left.) However, 
the arteriovenous difference can only be maintained by an increased 
flow in the coronary circulation (Niden, e^ , 1956). Their results 
show that, in an individual with diminished coronary circulation, because 
of coronary heart disease, a decrease in mixed venous oxygen tension of 
the myocardium precipitated by an inability to maintain the normal arterio-
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venous gradient. This hypoxic effect is further enhanced by an increase 
in cardiac rate and out-put as a general response to peripheral tissue 
hypoxemia. In this situation, a person with diminished coronary circu­
lation caused by coronary heart disease, consequently may be constantly 
near the point of myocardial tissue hypoxia (Ayres, et al., 1969).
The study of the relationship between CO poisoning and an ele­
vated titer of serum lactic dehydrogenase as an indicator of myocardial 
damage (Jaffe, 1968) indicated that even "normal" amounts of carbon 
monoxide may play an important role in the coronary attacks. Other stu­
dies observed a statistically significant aberration in the plasma lactic 
dehydrogenase isoenzyme distribution which was considered to be highly 
indicative of myocardial tissue damage (Lassiter, et al., 1972).
Another study of low level CO exposure to the percentage of pa­
tients who have coronary heart disease with angina pectoris showed that 
a small additional decrease in the oxygen saturation of blood brought 
about by mild exercise might be leasable. The degree of blood oxygen de­
saturation demanded with 10 percent COHb loading is rather severe (Dinman, 
1968).
In a study of normal young males and clinically normal middle 
aged males, low level CO with a treadmill exercise showed statistical dif­
ferences in the electrocardiogram (ECG) patterns. The investigators sug­
gested that the low-level CO exposure may augment the production of exer­
cise-induced myocardial ischemia in persons with preexisting subclinical 
heart disease, contribute to the development of myocardial dysfunction, 
and increase the arrhythmias (Anderson, et al., 1971).
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An interesting observation from the study of sheep in altitudes 
of 7000 meters presented significant evidence that oxygen breathing per­
mits the heart to do more work and reduces the amount of oxyhemoglobin 
causing the drastic change in brain and cardiovascular system and clot­
ting of the blood (Cheymol, et al., 1955). Important implications of a 
study of the effect of CO to the muscle fatigue and impairment of Og
transport to the tissues is made clear. Delayed recovery from CO induced
fatigue suggests intracellular binding of CO as mentioned above producing 
hypoxia. The affinity of CO for myoglobin and cytochrome oxidase may ex­
ceed that of hemoglobin. The binding of CO at either site could decrease
energy production, and in turn, the force of muscle fatigue (Petajan, et 
al., 1973).
It has been stated that enzymatic oxidations are sensitive to the 
traces of the inhibitors which are known to inhibit radical reaction chains, 
e.g., malonic acids, organic iodides, sulfites, cyanides, and CO (Mahler, 
et ^ . , 1966). Furthermore, CO is known to inhibit some respiratory en­
zymes which contain iron or copper atoms as an essential part of their cat­
alytic mechanism. Carbon monoxide is also known to react with microsome 
8^20» Perhaps the terminal oxidase for microsomal electron transport with 
either cytochrome b^ (liver mitochondrial microsome) or microsomal hydroxy­
lase functioning as an electron donor (Mahler, Ibid).
It has been shown that chronic CO intoxication in rats resulted in 
a decrease of activity in cholinesterase in blood serum, which can be used 
as an index for the degree of intoxication, and that changes in the or­
ganism under chronic exposure to CO are persistent, as demonstrated by the
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incomplete restoration of the activity of cholinesterase for three months 
after the inspiration of CO is stopped.
Studies of enzyme changes from exposure to low level CO (Rozera, 
et al., 1959) showed a decrease in erythrocytic phosphatase activity, and 
with continued exposure, a less decrease in erythrocyte alkaline phos­
phatase and serum phosphatase. Rabbits were used to show the effect of 
acute CO poisoning on riboflavin level in blood and tissues. It was 
observed that riboflavin was released to the blood via the muscles pro­
bably from protein decomposition, and that the differences between ex­
posed and controlled groups were statistically significant (Jerzykowski, 
et al., 1963).
Several specific alterations in the number of endocrine organs 
have been attributed to CO. Several cases of acute hyperthyroidism fol­
lowing exposure to CO and increased activity of the thyroid and decrease 
of tyrotropic hormone is evidenced by anatomical changes (Lilienthal, 
1950). It is found that repeated exposure to CO causes inhibition of 
gastrointestinal mcbility (Patterson, 1938).
An interesting study approached the conclusion that there is a 
correlation between CO level and automobile accidents'. A statistical 
and epidemiological strategy for this purpose has been developed and 
utilized (Ury, 1968) for studying the association of oxidant and auto­
mobile accidents. Neurophysiologic and behavioral effects of low-level 
to moderate CO exposures, were extensively reported.
These significant findings suggest deep concern for occupational
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safety and health considerations. Several studies have been reported 
concerning searches for the effect of low-levels of CO using objective eiec- 
trophysiological measures as spontaneous electroencephalograms (EEC), visual 
evoke responses (VER) sleep patterns, and conditioned electrocortical re­
flexes (Grudzinska, et al., 1963).
Several investigators have reported the effect of low-level CO 
exposure on the central nervous system (CNS) and changes in behavioral pat­
terns (Chappell, et al., 1967) on rats. In general, increasing COHb 
levels result in corresponding depression of the CNS showing a progres­
sion from slight headaches at 10-20 percent COHb, coma with intermittent 
convulsions at 50-60 percent, and death at 70 to 80 percent COHb. In 
the case of subclinical effects of low level CO exposure on CNS these are 
less well documented. The reason for this is that the current physiologi­
cal and toxicological methods are inadequately analyzing the subtle effects 
of chronic environmental pollutants (Beard, e^ , 1967). Chronic con­
tamination of the environment by various chemicals, gases, heat, radioac­
tive materials, noise, solid waste, sewage, and trace metals throughout 
the world has opened up many new areas of research. The ultimate aim of 
research and toxicologic studies is to determine the effects of pollutants 
on both human health and welfare. To obtain this it is essential to con­
duct animal studies to evaluate the potential toxicity of different pollu­
tants .
As mentioned earlier, CO is considered one of the most important 
and widely distributed urban atmospheric pollutants and reportedly consti­
tutes a health hazard. The fact that so few investigations have been con­
cerned with this gas and its effect on fibrinolytic activity and coronary
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thrombosis explains the failure of a literature search to reveal any 
other pertinent studies relevant to the etiological role of CO in fi­
brinolytic activities in the blood and coronary thrombosis. There have 
been no systematic investigations or careful accumulation of information 
in these aspects of CO poisoning.
Purpose and Scope
The purpose of the present investigation was to accumulate, study, 
elucidate, and amplify data concerning the effects of exposure of rabbits 
to low concentrations of CO on fibrinolytic activity.
In an effort to study the abnormalities in the blood clotting 
mechanism of low-level CO, rabbits were exposed to continuous 50 ppm CO 
for a period of 8 weeks. Blood samples were drawn twice a week for hemo­
globin, c a r b o x y h e m o g l o b i n ,  o x y h e m o g l o b i n ,  and blood fi­
brinolytic activity which was measured by whole blood clot lysis, a modi­
fied Fearnley technique, euglubulin lysis, fibrin plate, caseinolytic 
assay, fibrinolysis, serum fibrin/fibrinogen degradation products. Vascu­
lar and myocardial tissues changes were studied by microscope. Control 
and experimental rabbits were handled alike as far as possible, except 
that the experimental group was exposed to controlled amounts of CO. Urine 
was collected and studied for the fibrinolytic activity in rabbits of both the 
test and control groups. Carbon monoxide was measured with a Beckman in­
frared gasanalyzer. CO-oximeter and other advanced techniques were used 
for the measurement of oxyhemoglobin, hemoglobin, and carboxyhemoglobin.
A statistical model was developed to implement and expedite analysis
of small changes in large amounts of data. The data were subjected to 
analysis of variance, and the various treatment groups were compared 
by usingat-test and Duncan’s Multiple Range Test. A 0.05 statistical 
level of significance was chosen for this study.
In order to make sure that the elevated fibrinolytic activity 
was due to the plasminogen activator that was released from the endo­
thelial cells of the vessel walls, a third group of 6 rabbits were main­
tained under the same environmental condition in chambers. This time, 
concentration of the CO was increased to 300 ppm/8 hrs. for 5 days a 
week. A group of 3 rabbits were placed in one chamber and another 
group of 3 rabbits were placed in the other chamber. Both groups were 
then given the same concentration of CO (300 ppm/8 hrs) for 4 weeks. 
Concurrently a group of three rabbits were given epsilon-aminocaproic 
acid, (EACA, 200 mg/Kg) a known inhibitor of fibrinolysis (through 
inhibition of the activation of plasminogen).
Histological and microscopic examinations were done on all 
the experimental animals' myocardial and arterial tissues.
CHAPTER II 
LITERATURE REVIEW
The hemoglobin molecule plays an important role in oxygenation and 
deoxygenation of the blood. In order to understand the chemical asphyxia 
and physico-chemical changes in the body tissues it is necessary to under­
stand the physico-chemical behavior ofahemoglobin molecule as well as its 
relation to Og and CO gases.
Physico-chemical Behavior of Hemoglobin
Hemoglobin is a. conjugated protein consisting of an iron-contain­
ing porphyrin ring, heme, and a water soluble protein, globin. The mole­
cule is composed of four hemoglobin chains. Each hemoglobin chain is com­
posed of a globin moiety and a heme moiety. The globin moiety is a pro­
tein made up of over 140 amin o acids.
There are four common sequences, and it is suggested that (Ingram, 
1963) all these globin chains probably had a common evolutionary origin.
The heme moieties are always the same and have similar molecular structures. 
The heme molecule is planar, its iron being attached to the proximal and 
distal histidyl residues of a globin chain. Upon oxygenation, the oxygen 
(Og) slips between the Fe and the distal histidyle residues. The amino 
acid sequence only indicates the primary structure of the hemoglobin chain 
The protein has spring like a-helical regions which give the secondairy
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structure. Additional attractive forces twist the molecule into the 
worm-like tetramer formation.
Adult hemoglobin is formed when an a-chain (globin plus heme) 
and a g-chain associate to form a dimer and then two dimers associate 
to form a tetramer of the composition gg" four subunits are
irregular in shape, but rest together very tightly. The four hemes 
(iron plus porphyrin) lie semi-buried in non-polar crevices in their 
individual globins; water filling a cavity in the middle of the 
entire hemoglobin molecule.
The role of the hemoglobin molecule is the transport of oxygen, 
which it performs by virtue of its ability to combine with oxygen. The 
capacity to combine reversibly with molecules of oxygen without under­
going any demonstrable gross chemical change is the basis for its phy­
siologic function (Schejter, et al., 1963). The remarkable progress in 
defining both the chemical and stearic configuration of this molecule 
has allowed some tentative exploration of those chemical and physical 
factors which contribute to its function. Similar heme-containing chro­
mogen molecules, including the cytochromes and myoglobin, are widespread 
throughout the cells of the body. None of these has the characteristics 
of hemoglobin which, by virtue of its sigmoid-shaped oxygen dissociation 
curve, accepts molecular oxygen at relatively high tensions in the lungs 
and releases it to the tissues at relatively low tensions.
The evolutionary process apparently reached a functional compro­
mise in the structure of the hemoglobins because these molecules exist 
in physiological conditions as aggregates of monomeric hemoprotein chains. 
On the basis of this structure, several thermodynamic situations can cause
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the sigmoid shape of the titration curves of the hemoglobin-oxygen equi­
libria. Of these most widely discussed are those defined as intra mole­
cular and intermolecular interactions. The hypothesis of intramolecular 
interactions, which considers tetrameric hemoglobin as the only molecular 
species participating in the equilibrium, was first formulated by Adair 
(1925). This hypothesis implies that the hemes of a single molecule are 
not independent of each other in their affinity for oxygen. The mathe­
matical consequences of such a situation have been exhaustively analyzed 
by Wyman (1964) and its physical meaning is contained in the definition 
of free energy of intramolecular interaction. Very accurate measurements, 
especially at low and high percentages of saturations, permitted the esti­
mation of the microscopic association constants defined by Adair.
The concentration effect has been interpreted by Roughton (1965) 
as due to van der Waals interactions between adjacent tetrameric hemo­
globin molecules. The fundamental issue here is not, however, the nature 
of the forces involved in these interactions. The problem to be faced is 
whether it is correct to disregard the concentration effects in writing 
the equations that describe the hemoglobin-oxygen or carbon monoxide equi­
librium. Actually, the existence of concentration effects can be taken 
as evidence that the intermolecular interaction hypothesis is, at least to 
a certain extent, correct; concentration effects on the position of the 
equilibrium occur only in the reaction where there is a change in the num­
ber of molecules. There are cases for which the generalized stoichiometric 
equation (Schejter, et ^ . , 1963) applies almost quantitatively.
The kinetic model for the reaction of oxygen with hemoglobin is 
assumed to be expressed by
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k'
Hb + 0 ' HbO
k ^
There are several reasons for selecting this simplified overall approach. 
It has been shown (Gibson, 1959a; Gibson, 1959b; Moll, 1969c) to hold em­
pirically for the overall reaction and to be a good approximation to the 
Adair Intermediate Compound Hypothesis (Gibson, 1959) which is the gener­
ally accepted model for the oxygenation of the hemoglobin molecule.
The Adair kinetic model for the reaction of oxygen or CO with he­
moglobin is completed four successive reactions (Fleischmen, 1968).
Hb^ +
k;
k'/kj = Kj Hb^O^ + 0 2 = ^ H b j O j
3
k!
k'/k^ - Hb^Oj + O ÿ = ^ H b ^ O g
Similar reactions for carbon monoxide:
IJ/lj = Hb̂  + CO::?==iHb̂ CO
^1
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l̂ /lg = Hb^CO + C0^^==Hb^(C0)2
^2
4
l’/l3  = L 3  Hb^(C0)2 + CO ?=&±Hb^(C0)3
I3
J-;
I4/I4 = Hb^(C0)3 + CO:F=^Hb^(CO)^
- 4
The intermediate compounds of the reactions have not been clearly detected, 
but its clearly understood that hemoglobin mainly exists as either the com­
pletely unsaturated Hb^ or completely saturated Hb^Og state (Gibson, 1959).
The forward and reverse rate "constants" k' and k are actually not 
constants because of the accelerated oxygenation process resulting from 
the heme-heme interactions. In these four reactions k' is a function of 
all four of the intermediate (k')'s of the Adair model and it varies dir­
ectly with saturation due to increased importance of the k^, the fourth 
rate constant of the Adair model.
As a given saturation, k' and k are constants, and their ratio,
K = k'/k, represents the equilibrium constant for that saturation. How­
ever, as the saturation increases, the equilibrium "constant," K, increases 
too.
This K value can be calculated from the oxygen dissociation curve. 
The conditions from chemical equilibrium in whole blood between oxygen 
and hemoglobin are usually expressed in terms of the dissociation curve.
The dissociation curve gives the equilibrium relationship between the
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partial pressure of oxygen in the plasma and percent saturation of the 
hemoglobin in the red cells (Mochizuki, 1958).
The saturation refers to the fraction of the hemoglobin that has 
been oxygenated to form oxyhemoglobin. Since the solubility of oxygen 
in the red cells is known (Sendroy, et al., 1934) for a given partial 
pressure of oxygen in the plasma, it is possible to find the concentra­
tion of dissolved oxygen in the cell which is in chemical equilibrium 
with hemoglobin of a given saturation. This dissociation curve is a 
function of temperature and pH and has been reported (Karhan, 1968) at 
25°C for pH values of 8.6 and 8.1 respectively.
In the kinetics of hemoglobin reaction, it is important to con­
sider not only the rates for uptake and release of the iron ligand but 
also the rate of any ligand-link process, such as the Bohn effect, the 
effect of organic phosphates of ions of carbon dioxide in ligand associ­
ation and dissociation processes.
In the processes of kinetics, effects of ligand linked associa­
tion and dissociation of the hemoglobin tetramer, a2&2* reversibly 
dissociate into subunits of lower molecular weight aB dimers and single 
chain molecules. These association and dissociation equilibria may be 
ligand linked. These effects are due to association and dissociation 
processes expected to show up when kinetic experiments are performed un­
der conditions which favor dissociation (Churchill, 1960).
There are major factors which affect the rate at which red cells can 
take up oxygen and CO. Carbon monoxide combines with hemoglobin at the 
same site as does oxygen, both ligands attaching to the iron atom of the 
porphyrin group. The slow rate at which CO dissociates from carboxy-
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hemoglobin causes it to have an affinity for hemoglobin approximately two 
hundred fifty times as great as the affinity of oxygen. This enables CO 
in small concentrations to displace oxygen from hemoglobin thus reducing 
the oxygen carrying capacity of the blood, and is largely responsible for 
the toxicity of carbon monoxide.
Carbon monoxide binding tightly to hemoglobin produces hypoxemia 
in the short period of exposure. Another property of CO is that it com­
bines with hemoglobin less rapidly than does oxygen. This enables one to 
measure some of the CO reaction rates more easily and accurately than the 
corresponding oxygen reaction rates (Roughton, 1957). The gas uptake by 
the red cells can be explained briefly by reaction rates of the carbon 
monoxide and oxygen with hemoglobin. The methods for measuring the re­
action rates published by Hartridge and Roughton (1923) and much of the 
present knowledge is due to the intensive work of Roughton and his co­
workers .
The veloeity constants for the four successive stages of oxygena­
tion of the hemoglobin tetramer are given by the symbols kj, k^, kg, k^ 
and the constants for the deoxygenation of the tetramer by k^, kg, k^ and 
k^. The use of prime (’) indicates association velosity constant and it's 
absence indicates a dissociation velosity constant. For the reaction of 
CO with hemoglobin 1 is used instead of k. In cases where the overall 
rate of gas combination with reduced hemoglobin is measured, the symbol 
k' or 1* is used without a subscript. To describe the rate at which CO 
replaces oxygen from the fully saturated tetramer, Roughton, al. (1945)
introduced the symbol m' defined by equation:
d LCOHbi _ , [CO] [ ^ 2 ^
dt = " [Og]
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The value of m* is not constant but varies with the ratio CO / 0^ and 
thus is referred to as a pseudonstant rather than as a constant. Its 
relation to the more fundamental constants is expressed by the equation;
m = ----- i; CO
Roughton, Forster and Canden introduced the term m^ to describe the rate 
of the replacement reaction when the ratio CO / Og diffusing capacity 




The symbols of 1* and without the subscript "c" refer to reactions of 
hemoglobin in solutions. In describing the velocities of uptake of oxy­
gen and CO by reduced red cells the symbols k' and 1' are used and m ’ is
used for the rate of CO replacing 0. in cells.
k'
The definition of k* is Hb0«-==±Hb + 0»c z z
Og being the concentration of oxygen in the fluid immediately surround­
ing the red cells, and the reverse reaction again being neglected. Simi­
lar equation apply for 1^ and m \
The use of expressions for the apparent velocity constants for
gas uptake by cells has certain limitations. The rate must be measured
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as soon after the reactants are mixed as possible. This is because the 
equations of Roughton describing the combined processes of diffusion and 
chemical reaction into the cells are not valid except at zero time (Roughton, 
et al., 1957). The reverse reaction must also be neglected in order to 
solve the equations, the error introduced by neglecting it is minimized by
measuring the rate at zero time and, in the case of CO, by the inherent
slowness of the dissociation reaction. In the calculations all the combi­
nation velocity constants are second order and expressed in units of "li­
ters per millimole per second" which is equivalent to "per raillimolar per 
sec" abbreviated as mM ^sec The dissociation velocity constants and 
m', and m^ are first order and are expressed in units of sec
The fact that the sedimentation constants of hemoglobin and oxy­
hemoglobin at physiological concentrations approach the values expected 
for a tetreuner, seemingly militates against the existence of different 
intramolecular interactions, or affinities, in the two states. Neverthe­
less, a number of observations Indicated that dimers do exist even at 
large concentrations (Michaelis, ejt al., 1938).
Thus measurements of escape time through membranes indicate appre­
ciable deaggregation of carboxyhemoglobin at concentrations of 4mg/100ml 
(Guidotti, et , 1963). Another fact that is in keeping with intramole­
cular interaction hypothesis, while in open contradiction with the intra­
molecular interaction hypothesis, is the effect of salt concentration on 
the oxygenation curves (Barcroft, 1928a; Rossi-Fanelli, et al., 1961b).
In this case the direct relationship between the shape of the ti­
tration curves and the extent of deaggregation is clear. Molecular weight 
decreases, while the interactions increase, at higher salt concentrations
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(Rossi-Fanelli, , 1961). Some investigators pointed out that
this result is paradoxical in terms of the intramolecular interaction 
hypothesis (Antonini, 1965).
It is possible to envisage a compromise between both theories 
and the experimental facts, by assuming that the partially oxygenated 
intermediates are in equilibrium with their deaggregation products. 
This would lead to a system of consecutive boxes:
HI Hb^ (0%) " Hb (Og) 2 ^ - — ■ Hb^ (Og) 3-7- -  " -Hb^ (0%) ̂
°2 °2 °2 °2
2Hb'̂ :— - Hbg + Hb2(02) =;=i:2Hb2(02)-7==i:Hb2(02)2 + Hb2(02)^̂ ==̂ 2Hb (̂0̂ ) ̂
This complicated scheme does not include all the possible inter­
mediates. Distinguishable dimeric species may occur, due to the differ­
ent structure of the a and 6 chains. The hypothesis of consecutive boxes 
does not require appreciable values for the degradation constants of all 
the tetramene Intermediates. In fact, if only one of these intermediates 
splits into dimers the oxygenation curve will be sigmoid in shape.
In this sytem, free energies of deaggregation play the role re­
served for the free energies of intramolecular interaction in Adair’s 
hypothesis. If in addition, the latter have significant values, there 
will be a cooperative effect between both types of interactions.
It also appears that the effect of high salt concentration is 
greater on the aggregation constants than on the intramolecular interac­
tions. Undoubtedly the incorporation of aggregation constants complicates 
the estimation of thermodynamic parameters; at the same time, it takes 
into account concentration effects in agreement with the observed facts.
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The equations that will finally describe such a system will also 
permit quantitative prediction of the concentration effects and will allow 
estimation of the true magnitude of the intramolecular interactions. The 
system of consecutive boxes also suggests an explanation for the striking 
dependence of viscosity and dielectric increment of hemoglobin solutions 
on the degree of oxygenation. These properties do not vary steadily, but 
instead they increase and decrease twice, showing maxima at about 25% and 
75% saturation (Matsumiya, et , 1958a; Takashima, e^ al., 1958b).
In conclusion, it can be said that the effect of hemoglobin con­
centration on the hemoglobin-oxygen equilibria indicates that aggrega­
tion changes occur in the course of the reaction. From the results of 
modeling of the oxygenation process, it can be concluded that the oxygen­
ation process in whole blood is not diffusion controlled, but that the 
controlling mechanism is the reaction kinetics.
Based on the experimental results, a mechanism for oxygenation of 
whole blood with Intact red cells is suggested as follows. Oxygen enters 
the system by being physically dissolved in the plasma. However, an oxy­
gen gradient from the plasma to the cell exists such that most of the oxy­
gen is drawn out of the plasma into the red cell. Inside the red cell, 
the oxygen concentration stays at a relatively constant level for much of 
the oxygenation process. The oxygen entering the cells reacts with hemo­
globin to form oxyhemoglobin.
As the hemoglobin becomes saturated, the forward reaction rate is 
increased and the reverse reaction rate is decreased due to the heme-heme 
interaction. There is also the possibility of facilitated oxygen trans­
port due to the hemoglobin diffusion as the oxyhemoglobin concentration
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gradient increases (Moll, 1969). Thus, oxygen gradient into the cell 
would be maintained, and the level of oxygen within the cell would re­
main relatively constant until a sufficiently large amount of hemoglobin 
had been oxygenated to cause the diffusion terms to become significant.
Once this point is reached the oxygen uptake by the cells begins to slow 
down, and the level of oxygen is allowed to build up in the plasma.
The reactions are all aliostearic and result from intramolecular 
forces acting as intermediate equilibria occur. This reversible oxygena­
tion and deoxygenation of the hemoglobin molecule is extremely rapid, 
usually requiring less than .01 seconds (Aanong, 1971). Carbon monoxide 
is also taken up by hemoglobin almost as fast as 0^ but is released at 
a much slower rate and the half life of the CO in vivo is up to four hours 
(Bartlett, 1968).
Hemoglobin has four binding sites to which ligands such as oxygen 
or carbon monoxide can be attached. The reaction velocities for the suc­
cessive attachments (or dissociations) are not the same, which leads to 
an S-shaped dissociation curve as mentioned earlier. The dissociation 
constant for CO is markedly less than that of Og, with the result that he­
moglobin has affinity for CO about 210 times as great as that for 0^. The 
affinity constant varies with temperature and pH. This is expressed in 
the well-known Halden equation,
COHb _ ^CO
in which M is the affinity constant. Occupation of one of the four binding 
sites of hemoglobin by CO makes the molecule hold more tightly to the oxy-
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gen it carries, it will release 0^ only when there is a very low partial 
pressure of This is expressed as a shift to the left of the dissoci­
ation curve. Thus, not only is the total oxygen capacity of the blood 
diminished by CO, but even that oxygen which is carried is rendered less 
available to the tissues.
The shift of the dissociation curve of oxyhemoglobin is propor­
tional to the amount of carbon monoxide which is present, and that when 
COHb is below 10 per cent, the effect upon delivery of oxygen to the tis­
sues would not be very pronounced. Although the carbon monoxide-induced 
interference with delivery of oxygen to the tissues is of great signifi­
cance in cases of acute poisoning, it remains to be shown that it is im­
portant in the context of community air pollution.
The report takes note of this, mentioning that in vltrq studies 
of the influence of carbon monoxide on oxygen delivery rates of human 
blood could help to elucidate this matter. The reports rest mainly on 
the studies of the concentrations of CO in air, the concentration of O2 , 
the duration of exposure, and the physical activities of subjects (Forbes, 
et al., 1945).
These studies were able to show quite regular relationships which 
permitted the development of a nomogram from which COHb values can be 
predicted from ambient CO concentrations, duration of exposure, and pul­
monary ventilation rate or level of physical activity. They also show 
that the absorption of carbon monoxide is inhibited by increasing the 
partial pressure of oxygen in the inspired air.
The M value for a species remains relatively constant, depends 
upon the physiological conditions (Rodkey, et al., 1969). Because the 
tissue partial pressure of 0- (P- ) approximately 40 mm Hg in mixed venous
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blood) occurs at a steep portion of the sigmoid curve, under normal phy­
siological conditions oxygen is rapidly dissociated from hemoglobin re­
sulting in a tissue saturation which is maintained with a large oxyhemo­
globin reserve near the lower end of the curve. This reserve is the re­
sult of the large value of K^, which permits dissociation only at the 
upper portion of the curve under normal physiological conditions (Dinman,
1968).
The difference in the partial pressure of oxygen (P^ ) between
" 2
freshly oxygenated arterial blood P = 100 mm Hg) and mixed venous blood
" 2
(P. = 40 mm Hg) represents a release to the tissues of approximately 5
" 2
milliliters 0^/100ml of blood (Bartlett, 1968). The dissociation 
curve shifts to the right, allowing for a more efficient dissociation of 
oxygen tension (hypoxic hypoxia) (Lilienthal, 1950). The leftward shift 
during CO exposure occurs because of the much greater affinity of CO for 
hemoglobin and in spite of the fact that the amount of oxygen in physi­
cal solution in the blood remains close to normal (Bartlett, 1968). The 
oxygen content of the blood is not only lowered during exposure to CO, 
but the shift of the oxyhemoglobin dissociation curve to the left decreases 
the amount of remaining oxygen that is made available to the tissues. Both 
mechanisms serve to effectively lower the tissue P^ and hence can create 
a generalized tissue hypoxia (Dinman, 1968). Some investigators in the 
field suggested that the great affinity of hemoglobin for CO was a defi­
nite survival advantage since this mechanism permits the expedient removal 
of endogenously-produced CO resulting from the heme catabolism. Some in­
vestigators believe that if any acclimatization occurs it is the only re­
sult of the accumulated effects of repeated episodes and not merely
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a continuous Insult by low levels of CO (Rossiter, 1942a; Zoru, et al., 
1960b).
Since complete acclimatization to ambient concentrations of CO 
may not be possible, biological alterations occuring during exposure to
CO become suspect as indicators of possible deleterious effects. The
same would still be true should acclimatization to CO occur. This rea­
soning has even led some investigators to believe that death resulting 
from acute CO intoxication may not be caused solely by simple asphyxia 
(Suzuki, 1969a; Lilienthal, 1946b) but also by some toxic effect exerted 
by CO.
Carbon monoxide is eliminated from the body via the lungs. The 
reaction is a reversible one, and the rate of elimination is governed 
by the same factors that affect its absorption (Stewart, et al., 1960).
The reversible reactions of hemoglobin and myoglobin (Mb) take place in 
the following reactions:
1) CO + Hbti=îHbCO
2) CO + Mb-^^MbCG
The reaction of CO with Mb is physiologically and physiochemically signi­
ficant, but less important than CO combining with Hb.
The treatment of CO poisoning as described by Smith and Sharp in 
1960 was administration of oxygen at high atmospheric pressure (Bour, et 
al., 1967). The results showed that the period of hypoxia was terminated 
as soon as the amount of oxygen dissolved in the plasma was sufficient to 
adequately oxygenate the tissues. The elimination of CO took place more 
rapidly, resulting in Increased alveolar oxygen tension. The unconscious 
patient, when his breathing is failing or is temporarily arrested, requires
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artificial respiration and the method of choice is that of Schater or 
Holger-Nielsen, admirably described and depicted by Garland (1955). The
3latter gives a greater tidal volume (580 cm ) than the Schater back-
3pressure method (185 cm ).
Although breathing fresh air may be sufficient, clearance of 
carbon monoxide is hastened if the patient can breath oxygen mixed with 
5 percent carbon dioxide. Haldane (1895) experienced prompt relief when 
he breathed oxygen along at the conclusion of his experiment. In 1930, 
following Henderson and Haggard (1927),he recommended the addition of 
carbon dioxide in a proportion of 7 percent.
Among the most subtle of known physiologic alterations are those 
which involve shifts in compartraental concentrations of trace metals.
New techniques (atomic absorption and anodic stripping voltametry) now 
allow for the detection of very minute amounts of these important entities, 
and changes in their departmental concentrations during the course of 
various disease states, including chronic CO exposure, have been docu­
mented (Mazaleski, et al., 1970a; Pecora, 1964b).
Difficulties involved in determining the significance of findings 
and in the extrapolation of findings to the whole organism have, so far, 
somewhat undermined the potential values of these techniques. However, 
the fact that most of the eight essential trace metals participate, phy­
siologically, either as co-factors or activators of enzymes underscores 
the importance of determining their aberrations in vivo. In fact, any 
condition precipitating changes in enzyme activity or concentration merits 
very close scrutiny, and the activity of several enzymes has been found 
to be altered during CO exposure (Halperin, et al., 1959a; Rozena, et al.,
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1959b).
It should be emphasized that these early and many other later in­
vestigators have stressed the fact that the effect of CO on man is en­
hanced by many environmental factors. These have included rate of exer­
cise, high environmental temperatures, altitudes above 2000 feet, and si­
multaneous exposure to narcotic solvents.
From the viewpoint of health, limiting occupational exposure to 
CO to a TWA (time weighted average) concentration which will produce no 
greater than 5 percent COHb may not provide a margin of safety for the 
employee with clinical symptoms of coronary heart disease. The American 
Conference of Governmental Industrial Hygienists (ACGIH) Committee on 
Threshold Limit Values recommended 100 ppm for CO in 1945, and in 1965 
the conference recommended that the limit be reduced to 50 ppm, a value 
that was officially adopted by ACGIH in 1967.
In recommending the lower value the Committee stated that condi­
tions of heavy labor, high temperatures of work 5000-8000 feet above sea 
level, the threshold limit value should be reduced to 25 ppm. No fur­
ther benefits under any circumstances could be expected by reducing the 
level below 5 to 10 ppm since at this concentration one is practically 
in equilibrium with the normal blood level of one percent COHb. The re­
commended TLV for CO of 50 ppm is thus based on air concentration that 
should not result in blood CO levels above 10 percent, which is a de­
velopment of the sign of borderline effects.
Furthermore, the U.S. Navy established a limit for the average 
concentration of a continous exposure to CO for prolonged submarine voy­
age at 25 ppm, and the National Aeronautics and Space Administration
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considered 15 ppm CO to be maximum average concentration for space 
flights.
The American Industrial Hygiene Association has recommended a 
community air quality guide for CO exposure of 20 ppm as an eight-hour 
average, which is stated to be equivalent to 3 percent COHb. In addi­
tion a limit of 70 ppm has been recommended for a one-hour period, which 
is also stated to be equivalent to 3 percent COHb.
The recommended limits are based on levels of CO concentration 
which will not exceed one-half of the 5 to 6 percent COHb prior to to­
bacco consumption. It was considered that the recommended CO concentra­
tions would permit susceptibles with heart disease to obtain a time based 
margin of safety prior to reacting the 5 to 10 percent COHb range.
Although the conditions by which a level of 5 percent COHb is 
reached is variable in individuals, dependent upon such parameters as 
activity, altitude, length of exposure, and CO concentration, as well 
as individual differences in the CO uptake, the smoker who engaged in 
sedentary activity will approach this level in eight hours if continuously 
exposed to 35 ppm of CO.
Basis for Recommended Standard
The recommended standard is based on the cardiovascular and be­
havioral evidences which generally documents the initiation or enhance­
ment of myocardial alterations in individuals with coronary heart dis­
ease (CHD) who exposed to CO concentrations sufficient enough to produce 
a COHb level greater than 5 percent. Recent extensive studies are de­
monstrating restricted coronary blood flow and myocardial lactate pro­
duction under such circumstances and concerning CO exposure and exercise
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of patients with angina pectoris are germane to the recommended stan­
dard (Knelson 1972a; Ayres, et , 1969b).
The synergistic relationship imposed by chronic ciga­
rette smoking and concomitant exposure to CO upon the enhancement of such 
detrimental myocardial alterations were reported by the Surgeon General (The 
Health Consequence of Smoking, 1971). Based on the available evidence, 
the imposition of a COHb level of 5 percent on an active worker with 
clinical or asymptomatic CHD is unwarranted.
There are certain difficulties in measuring and extrapolating 
5 percent COHb of the worker in relation to a meaningful ambient CO con­
centration in the work place. At first, air sampling methodology must 
depend on the statistical techniques to develop an eight-hour, time- 
weighted, integrated analysis. Secondly, the rate of the activity of 
the worker will increase the exposure to CO by decreasing the length of 
time to COHb equilibrium and by maintaining a higher COHb level in the 
active worker than in the sedentary worker who has not reached equilibri­
um. The significance of the first difficulty can be practically resolved 
by an air sampling protocol which will insure that sufficient quantities 
of such samples are taken to provide a reliable, statistical estimation 
of proposed eight-hour standard. The activity factor can be minimized 
by an equation which takes into consideration, among other parameters, the 
activity of the worker in terms of alveolar ventilation rate and pulmonary 
diffusion rate (Cobum, et al., 1965).
The recommended TWA standard of 35 ppm CO is based on a COHb le­
vel of 5 percent, which is the amount of COHb that an employee engaged in 
sedentary activity would be expected to approach in eight hours during
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continuous exposure. The ceiling concentration of 200 ppm is based on 
the restriction of employee exposure to CO to transient excursions above 
35 ppm which would not be expected to significantly alter his level of 
COHb.
The recommended standard is based on the utilization of the CO 
for an eight-hour work day. The applicability of the equation for this 
purpose has been validated by a study of Peterson and Stewart (1970).
While the values assigned to several of variables in the equa­
tion by the investigators were for sedentary individuals (e.g., alveo­
lar ventilation rate of 6 liters/minute, CO pulmonary diffusion rate of 
30 milliliters/minute/mmHg), it is recognized that the range of activi­
ties of the worker in the work place may vairy considerably. It is in­
cumbent on the employer to recognize the effect that the level of acti­
vity has on the uptake of CO and judiciously evaluate the exposure of 
his employees and limit their activities accordingly. In addition, the 
employer must give special consideration to limiting the activity of em­
ployees exposed to CO at high altitudes in order to compensate for dual 
loss in oxygen-carrying capacity of the blood.
The Environmental Protection Agency (EPA), under provisions of 
the Clean Air Act (PL 91-604), promulgated national primary and second­
ary air quality standards on April 30, 1971. The primary and secondary 
standards for CO are:
1) 10 milligrams per cubic meter (9 ppm) - maximum eight-hour
concentration not to be exceeded more than once per year.
2) 40 milligrams per cubic meter (35 ppm) - maximum one-hour
concentration not to be exceeded more than once per year.
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Promulgating this standard the Administrator of EPA made the following
statement (Stewart, e£ al., 1970) concerning comments raised about the
evidence used to support the proposed standard:
In the comments, serious questions were raised about the 
soundness of this evidence. Extensive consideration was gi­
ven to this matter. The conclusions reached were that the 
evidence regarding impaired time-interval discrimination had 
not been refuted and that a less restrictive national stan­
dard for CO would therefore not provide the margin of safety 
which may be needed to protect the health of persons especi­
ally sensitive to the effects of elevated carboxyhsmoglobin 
levels. The only change made in the national standards for 
CO was a modification of the 1-hour value. The revised stan­
dard affords protection from the same low levels of blood car- 
boxyhemoglobin as a result of short-term exposure. The na­
tional standards for carbon monoxide, as set forth below, are 
intended to protect against the occurrence of carboxyhemoglo- 
bin levels above 2 percent. It is the Administrator's judg­
ment that attainment of the national standards for carbon mo­
noxide will provide an adequate safety margin for protection 
of public health and will protect against known and antici­
pated adverse effects on public welfare.
The air quality standard is designed to protect the population-at-large
and takes into consideration 24-hour per day exposure of the young, the
old and the ill.
Fibrinolysis and Thrombosis 
The concept of thrombosis was developed largely through anatomic 
observations. For centuries, the development of the concept was hindered 
by the lack of general recognition that blood in the heart and blood ves­
sels may solidify after death as well as during life (Millikan, 1958a;
U.S. Department of Health, Education and Welfare, Public Health Service, 
1962b). The confusion that existed until well into the nineteenth century 
is best Illustrated by the well known history of the problem of heart po­
lyps. The problem concerned the distinction between polyps that were true
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thrombi and possessed "vitality" and polyps that were simply postmortem 
coagula (Eisenberg, et al.. 1564). The pathologic nature of a thrombus 
was determined mainly by these anatomic observations: evidence of degen­
eration during life, lamination, and adherence to the vessel wall (Bronte, 
e^ , 1964a; Eisenberg, e^ , 1964b; Hodge, et , 1966c). The recog­
nition of the effects of ischemia caused by thromboembolization made it 
quite clear that thrombi have vitality (Wylie, 1962).
Experimental studies established that thrombi of a distinctive 
structure from inflowing blood from constituents of blood (Dorn, 1959a; 
Kallner, 1958b). Natural thrombi were found to have the same basic struc­
ture and constituents, indicating a similar mode of formation (Kallner, 
1958a; Katsuki, et ^ . , 1964b). Variations in structure, although observed 
and beautifully illustrated as early as 1805 by Jones were not fully under­
stood until it was shown how disturbances of blood flow influence the struc­
ture and development of a thrombus (Marshall, 1964a; Aurell, et al., 1964b; 
Ueda, 1962c). Welch, in his noted review of 1899, summarized the experi­
mental and morphologic studies that led to the concept of thrombosis as we 
know it today (Eisenberg, et al., 1964). His definition of a throm­
bus, "a solid mass or plug formed in the living heart or vessels from con­
stituents of blood" is widely used (Takahashi, et al., 1961). Although 
the main aspects of the nature of a thrombus were worked out by the end of 
the nineteenth century, there have been contributions since then, especi­
ally by the application of recently developed techniques such as electron 
microscopy, enzyme histochemistry and immunofluorescent microscopy.
Formation of fibrin is an important stage in hemostasis, thrombo­
sis and tissue repair because the fibrin formed solidifies the hemostatic
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platelet plugsand provided a matrix for the formation of reparative con­
nective tissue with fibroblastic proliferation and growth of capillaries. 
Ultimately, the fibrin has to be removed, mainly by the process of fibrin­
olysis, in order to restore normal conditions. Fibrinolysis is caused by 
the blood proteinase, plasmin. Plasrain (fibrinolysin) is formed from a 
precursor, plasminogen (profibrinolysin), abundantly present in blood plas­
ma (Kaulla, 1963). Plasminogen is transformed to plasmin by a variety of 
activators. Inhibitors regulate the activation of plasminogen as well as 
the effect of plasmin (Feamley, 1965a; Konttinen, 1968b). In the living 
organism, a dynamic equilibrium, or hemostatic balance, exists between fi­
brin formation and resolution. Disturbances in this balance may lead to 
impaired or to excessive fibrin formation and, consequently, to impaired 
hemostasis or pathological tissue repair (Sherry, 1969 ). The involvement 
of the mechanisms of blood coagulation and fibrinolysis in the regulation 
of tissue repair signifies them as fundamental physiological processes, 
important not only in hemorrhagic disorders and in thromboembolic diseases 
but playing a role in a multitude of pathological conditions (Frohlich, 
1972). Fibrinolysis bears an obvious relation to thrombosis: the end pro­
duct of thrombosis, the thrombus, depends on fibrin for its tensile strength 
and structural integrity (Sherry, 1969). However, the relationship between 
the two processes is considerably more intimate, in that it is evident that 
a thrombus is not static, but rather provides an interface at which the dy­
namic events of thrombosis and fibrinolysis continuously overlap (Astrup, 
1956). As a consequence, it is increasingly apparent that the study of 
thrombosis must include fibrinolysis as an integral part.
Rapid strides were made in understanding how the fibrinolytic enzyme
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system worked when it became apparent that the fibrinolytic activity 
of plasma was directly related to its plasminogen activator content 
(in fact, was measure of it), (Albrechtsen, 1956) that plasminogen was 
deposited, and (Ambrus, e£ , 1962) that plasminogen activation in 
the immediate proximity of fibrin (e.g., in the interstice of a clot) 
was the most sensitive mechanism for fibrinolysis (Kwaan, e^ , 1965). 
This has led to the development of a hypothesis (Kirk, 1962a; MUllertz, 
e^ , 1954b; Todd, 1960c; Sherry, 1969d) that appears to account for 
the facts: in vivo, plasminogen exists as a two-phase system, a soluble
phase in the body fluids (plasma plasminogen) and a gel phase in throm­
bi and fibrinous deposits (Glas, et , 1967a; Janda, 1965b; Coccheri, 
et al., 1961c). The effect of activators in the two phases and the con­
sequences of plasminogen activation in the two sites are dissimilar 
(Sherry, 1969). Minor or slow activation of plasma plasminogen, because 
of the presence of inhibitors, will not result in detectable signs of 
plasma proteolysis, because the enzyme is effectively inhibited on its 
formation; but rapid activation of plasma plasminogen produces excessive 
plasma proteolysis, resulting in the rapid degradation of fibrinogen, 
the most abundant available substrate. However, activation of gel phase 
or clot plasminogen, resulting from diffusion or incorporation of the ac­
tivator into the clot, produces fibrinolysis, (Ibid;) for here the enzyme 
is activated in the presence of fibrin, which is the only substrate avail­
able, and the reaction appears, at least initially, to be independent of 
inhibitors in the body fluids.
These considerations attach great specificity to fibrinolysis, 
in that, under physiologic circumstances, fibrinolytic phenomena appear 
to be regulated by the concentration of plasminogen activator. Plasminogen
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activator is present in blood, and various body fluids and secretions 
such as urine, milk, saliva, tears, seminal fluid and cervical mucous.
Our present knowledge of the various activating and inhibiting 
steps within the fibrinolytic enzyme system is represented in the fol­




































FIGURE 1. Schematic Pathway of Fibrinolysis
43
is released transiently into the circulation and directly raises the 
clot-dissolving activity of the plasma by its ability to activate gel 
phase plasminogen, but without invoking the consequences of increased 
plasma proteolysis (Ashford, et al., 1967). The mechanism is particu­
larly effective if significant quantities of activator are present when 
fibrin formation occurs, (Sherry, 1969) under these circumstances, the 
activator is incorporated into the clot while it is forming, and the 
subsequent widespread activation of clot plasminogen leads to very ra­
pid fibrinolysis.
The fibrinolytic mechanism appears to be continuously active, 
and it is dynamic in response to stimuli. Enhanced fibrinolytic acti­
vity is observed frequently in some diseases— e.g., hematologic malig­
nancies, cirrhosis of liver, and various infections. The physiologic 
and pharmacologic stimuli also producing changes in fibrinolytic acti­
vities such as electroshock, pneumoencephalography, hypoglycemia, ische­
mia, anoxia, intense exercise, and parenteral injections of epinephrine, 
acetylcholine, nicotinic acid, or pyrogen (Duckert, ^ . , 1960). Fi­
brinolysis is viewed as a local phenomenon for years but there is enough 
evidence to believe that plasminogen activator is released into the cir­
culation at the site of ischemia or other acute vascular change, by vaso­
dilatation or vasoconstriction (Fearnley, 1965). Plasminogen activators 
(Kaulla, 1963), are derived from both exogenous and endogenous sources.
Most exogenous activators consist of bacterial products such as strepto­
kinase and staphylokinase. The endogeneous or physiologic activators, 
are found in blood and tissues. The tissue activators are found in all 
organs of the human body, with the exception of the liver. It was recently
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observed that in the kidney, the tissue activator is associated with 
lysosome traction (Ali, et al., 1965). Further information on the chem­
ical nature of the physiologic blood and tissue activator is very limited, 
except in the case of urokinase, an activator present in urine (Walton,
1967). The identity or non-identity of urokinase with tissue and blood 
plasma activator is being discussed.
The inhibitors of the fibrinolytic enzjnne may also be of exogen­
ous or physiologic origin. There are several synthetic inhibitors. Ep­
silon amino-caproic acid is the most significant one (Norman, 1966). It 
possesses both antiactivator and antiplasmin qualities, and which is known 
to be an effective anti-fibrinolytic agent in the treatment of hemorrhage 
due to pathologically increased fibrinolytic activity. Another exogenous 
inhibitor which has proven value in clinical application is Trasylol , 
and a small peptide extracted from bovin salivary glands and lung tissue. 
There are two antiplasmins that are referred to as alpha-1 and alpha-2 
antiplasmin (Ibid.).
Alpha-1 antiplasmin possesses a slow and non-dissociable inhibit­
ing effect. It is temperature dependent, and is destroyed after being in­
cubated at 56°C for 30 minutes, dissociable from plasmin and much less 
temperature sensitive. Recently the role of alpha-2 macroglobulin has been 
emphasized. Antiplasmin activity can be demonstrated in various other 
tissues, such as lung, liver, and even within seminal fluid, ovarian fol­
licles and cervical mucous (Kaulla, 1963).
Fibrinolysis has been inhibited in man for therapeutic purposes, 
both for systemic states of excessive fibrinolysis and to control local fi­
brinolytic agents, epsilon-aminocaproic acid, trasylol, p-aminomethylcyclo-
hexanecarboxylic acid, (Cutler, 1967), and p-aminomethylbenzolc acid 
(Markwardt, 1965).
Physiologically, fibrinolysis is accomplished without a signifi­
cant increase in plasma proteolysis. But sometimes there is excessive 
digestion of fibrin or fibrinogen. This state is associated with an a- 
cute or chronic coagulation disorder, and when the onset is sudden, a 
serious hemorrhagic diathesis may develop rapidly with severe bleeding. 
Although the blood of man or animal suffering from this disorder fre­
quently demonstrates multiple coagulation defects, among the most com­
mon ones poor and slow clotting, even after the addition of thrombin; 
and, if a clot forms, it is loose and friable. The clot may undergo 
spontaneous dissolution in a matter of minutes or hours, and that makes 
the syndrome recognizable; it is referred to as "pathologic fibrinolysis" 
or "fibrinolytic bleeding." The severity of this disorder can be readily 
attributed to the particularly ineffective form of hemostasis present, 
clotting is slow and inadequate, and the clot may later dissolve (Sherry,
1969).
The understanding of this hemorrhagic diathesis has come from 
studies that demonstrated that the products of the proteolytic digestion 
of fibrinogen and fibrin interfere with blood clotting, and that the addi­
tion of such proteolysis products to normal blood, in vitro the abnormal 
blood clotting seen in the fibrinolytic disorders (Kuller, ejt ^ . , 1967; 
Triantaphyllopoulos, e_t , 1965b). The appearance in plasma of break­
down products during states of excessive fibrinogen or fibrin proteolysis 
can be demonstrated most readily by immunologic techniques (Merskey, et. 
al., 1966) and the fragments can be characterized as the type by immuno­
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electrophoresis (Harder, et al., 1969). However, under clinical condi­
tions, the coagulation disorder can be screened for most simply by mea­
suring the thrombin clotting time. In the presence of excess thrombin, 
the thrombin clotting time is virtually a measure of the polymerization 
time, as a result, the thrombin clotting time, although lacking specifi­
city, is useful. Thus, the immediate problem in the fibrinolytic dis­
orders is related not tn the level of fibrinolytic activity or plasmin 
in the circulation but to the presence of abnormal amounts of fibrinogen 
or fibrin breakdown products, which arise as a result of the excessive 
digestion of fibrinogen or fibrin. These breakdown products, in high 
concentrations seriously interfere with the normal clotting mechanism 
and precipitate a severe hemorrhagic diathesis. The fibrinolytic enzyme 
measurements consist mainly of indirect determinations. Overall blood fi­
brinolytic activity is simply observed following the incubation at 37°C 
of the diluted or undiluted whole blood or plasma clots. The decreased 
fibrinolytic inhibitor activity after dilution causes the faster dissolu­
tion of blood clots.
There are several ways to measure plasminogen activators. One 
method is by observing lysis time of the clotted euglobulin fraction which 
contains most of the activator present in the blood. Euglobulin fraction 
is obtained by lowering plasma ionic strength and pH of plasma. The eu­
globulin precipitate is recovered practically free of antiplasmin. The 
euglobulin lysis time is inversely related to the activity of plasminogen 
activator. Activation of plasminogen to plasmin results in the digestion 
of the fibrin network of the euglobulin clot and eventually lysis of the 
clot without any interference by antiplasmin. In the second method, the
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excess quantity of plasminogen of plasminogen-rich fibrin clot serves as 
a substrate for testing plasminogen activator. The amount of plasmino­
gen contamination found in a solution to be tested for activator activity 
would be a negligible when compared to the plasminogen already present 
within the substrate. Consequently the extent of fibrin digestion will 
reflect the activator activity present in the activation of plasminogen 
to plasmin (the latter causing the dissolution of the fibrin substrate). 
The plasminogen-fibrin substrate is clotted in petri-dishes upon which 
the test solution is applied. The resulting lysis zones are a measure 
of activator activity. The method is known generally as the fibrin plate 
technique. In the third method, the moderately reduced fibrinogen level 
measured by the methods of Partenjez or Kjeldahl. In the fourth method, 
excessive amount of immunologically identifiable fibrinogen breakdown 
products measured.
The plasminogen determination is also indirect. An excess of 
purified plasminogen activator such as urokinase or streptokinase is used 
to activate plasminogen to plasmin. Plasmin in turn is allowed to di­
gest a protein substrate,casein, used in most cases. The quantity of 
protein substrate digested by formed plasmin will be measure of plasmino­
gen.
Plasmin can be measured directly. The substrate used can be
either fibrin or other proteins such as casein or synthetic amino acids
esters. Antiplasmin is indirectly determined by measuring the remaining 
plasmin activity after standard period of incubation with test solution
having a known concentration of plasmin. Anti-plasmin activity is the
measurement of the ability to neutralize plasmin.
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Control of the primary fibrinolytic disorders accomplished by ad­
ministrating the synthetic amino acid, epsilon-aminocaproic acid. Shortly 
after the oral administration of this agent in appropriate dosage (load­
ing dose of 100-200 mgm/Kgm/day) plasma plasminogen activation ceased and 
fibrinolytic activities decreased spontaneously (frequently dramatically).
The secondary fibrinolytic disorders are seen in association with 
the disseminated intravascular coagulation syndrome (also referred to as 
"diffuse intravascular clotting," "acute defibrination syndrome" and "con­
sumption coagulopathy"). Present evidence indicates that most of the 
acutely acquired hypofibrinogénémie disorders encountered clinically (i.e., 
those in which plasma fibrinogen is strikingly reduced) are due to dissem­
inated intravascular coagulation. Fibrinolysis contributes significantly 
to this disorder, usually as a secondary local response but sometimes be­
cause of simultaneous release of tissue thromboplastin and tissue activa­
tor into the circulation (Kowalski, et al., 1965).
Because of the overlapping findings and the lack of a specific 
diagnostic test, the differentiation between protracted intravascular 
clotting complicated by secondary fibrinolysis (fibrin degradation) and 
primary fibrinolytic disorder (fibrinogen degradation) may be extremely 
difficult. Nevertheless, recognition of the problem should lead to the 
development of new laboratory methods capable of making this distinction 
accurately, so as to provide a more scientific and effective therapeutic 
approach.
At present, reliance on good clinical judgment and careful labora­
tory study (of the amount of increased circulating fibrinolytic activity, 
the severity and nature of the coagulation deficiencies, decrease in
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platelet numbers, etc.) will help to resolve this difficulty.
At the present cime, our knowledge of biological chemistry is 
far advanced in results of fibrinolytic enzyme system research. The 
molecular basis and kinetic character of several fibrinolytic enzymes 
(plasminogen, plasmin and urokinase) have been extensively investigated. 
This information, unfortunately, is in some sort of comparative imbal­
ance with that available on the physico-chemical significance of the 
fibrinolysis system. The role of the fibrinolytic system in body phy­
siology is not yet well defined. Fibrinolysis as the physiological 
counterbalance to coagulation is being discussed, but not yet either 
proved or disproved. This role of fibrinolytic activity as a counter­
balance still remains as a hypothetical statement with little additional 
information forthcoming from the last two decades. Knowledge about the 
site of origin of fibrinolytic enzymes and the regulating mechanism of 
this system is also very sketchy.
Intravascular clots are one of the most frequent causes of death 
(Kaulla, 1963a; Merskey, et ^ . , 1963b). Theoretically, the formation 
of intravascular clots should be counteracted by increasing the body's 
fibrinolytic potential. A significant future contribution to preventa­
tive medicine would be the discovery of an ideal therapeutic agent for 
preventing this cause of death.
It became apparent in the last decade that a considerable body 
of pertinent information was being obtained which served to tie together 
the relationship between interfacial phenomena, thrombosis and hemostasis. 
Available information in this area had been acquired by a veiry small group 
of investigators who exchanged and complemented each other's findings.
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but did so in a very narrow spectrum without wide dissemination of their 
results. At present, considerable effort and interest were made by the 
members of such diverse specialties as vascular surgery, hematology, bio­
chemistry, biophysics, and engineering.
If fibrinolysis counter-balances blood coagulation, intravascular 
clotting should represent an imbalanced stage. Production of more infor­
mation along these lines will better the chances of solving this problem.
The Present Knowledge of the Roles of Vascular System 
and Circulating Blood in Relation to 
the Fibrinolytic Enzyme System
According to Mole, the fluidity of blood after sudden death al­
ready had been recognized in 1871 by Virchow (Loewy, er ^ . , 1954). In 
1906 Morawitz showed that blood obtained at postmortem was fluid, free 
from fibrinogen, and at times fibrinolytic. Fidon, Gautier and Martin 
in 1908 and Oki in 1934 demonstrated the occurrence of fibrinolysis in 
experimentally asphyxiated dogs. Yudin in 1936 took the advantage of the 
unclotted blood in persons succumbing by violent death for transfusion 
purposes. Mole made a further excellent study on postmortem blood (Mole, 
1948). He found in those who died from infection and cachexia, that the 
blood was clotted, whereas, in the majority of sudden deaths of previously 
healthy persons, the blood was fluid. Absence of fibrinogen and presence 
of fibrinolytic activity in these blood samples was confirmed. The ly­
tic activity was centripetally decreased, blood from limbs being more 
active than blood from the heart. Portal blood behaved similarly to heart 
blood and there was no difference between blood from the right or left
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heart chambers. No evidence for the release of fibrinolytic activity 
from any particular organ was obtained. There was an approximate in­
verse relationship between the activity of fibrinolysis and the dia­
meter of the vessel from which the blood sample was obtained. Mole 
suggested that fibrinolysis might be the product of the vascular endo­
thelium. He also mentioned leucocytes as another possible source of 
fibrinolytic activity. Tagnon and his associates studied 22 patients 
with peripheral vascular collapse (rapid pulse, low blood pressure, cold 
and sweaty extremities) due to various causes. Eight patients had in­
creased fibrinolysis (Tagnon, ^1., 1946). Of these eight patients, 
four were in severe hemorrhagic shock, three were extensively burned 
and one probably was poisoned by a barbiturate. Then these authors 
induced hemorrhagic shock in 13 anesthetized dogs. Six dogs died in­
stantly from improper handling, five of the remaining dogs showed a 
marked increase in fibrinolysis two hours after the onset of shock. In 
another group of their experiments, five dogs were bled to death within 
five to eighteen minute periods. Blood samples were withdrawn every 
one to two minutes. Fibrinolysis was observed to develop in three dogs. 
It was concluded that shock could induce fibrinolysis in certain cases 
while in the rest, the time of sampling might have been inappropriate.
The fibrinolytic enzyme could originate either from within the plasma 
or be derived from cellular elements by damage to the tissue. Kwaan and 
McFadzean were the first to induce local fibrinolysis within the body 
(Kwaan, et al., 1956). They showed increased fibrinolytic activity in 
blood withdrawn from an ishcemic arm compared to the sample obtained from 
the opposite control arm. This fibrinolysis was increased progressively
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in the intensity in a centrifugal manner as shown in successive samples 
withdrawn from the same ischemic arm. investigators suggested the possi­
bility of release of fibrinolytic activity from small arterial trees or 
from the capillary beds. Paravenous or intravenous injection of adrena­
line or acetylcholine under conditions preventing rapid absorption of 
the drugs (by pre-application of tourniquet at diastolic pressure above 
the injection area) induced fibrinolytic activity in that vein. This in­
duction could not be observed when the arterial flow was obstructed. Atro­
pine also prevented this induction. Thrombi produced in an isolated seg­
ment of the rabbit's ear vein were spontaneously lysed. Therefore, it 
was suggested that fibrinolytic activity is released from the venous wall
and that direct stimulation of cholinergic receptors were involved in
this release. Pandolti and his associates, on the other hand, were able 
to show increased blood fibrinolytic activity after venous stasis at a 
pressure mid-way between systolic and diastolic pressure. Lysis of throm­
bi in opened segments of rabbit ear veins was enhanced by injection of 
adrenaline and serotonin (5-hydroxy-tryptamine), whereas atropine delayed 
it (Kwaan, et al., 1958a; Warren, 1963b). The enhancement by serotonin 
was more pronounced if given by the paravenous route rather than intra­
venously. Corticotrophin inhibited the effect of the serotonin but not 
of adrenaline. Corticotrophin is claimed to have an inhibitory effect 
upon monoamine oxidase, an enzyme which is able to oxidize serotonin.
This explains the better stimulating effect of serotonin when given para- 
venously. Atropin exerted a vaso-dilating effect while adrenaline and 
serotonin caused vasoconstriction. A hypothetic statement was made that 
vasoconstriction, especially of the vasa vasorum, might cause ischemia
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of the venous wall and thereby trigger the release of plasminogen acti­
vator. This, however, is at variance to what the authors had suggested 
in their previous report concerning the requirement of flow through the 
vasa vasorum for releasing plasminogen activator (Kwaan, et , 1957).
The nature of the fibrinolytic enzyme system involved was not known, but 
the authors suggested the possibility of it being a plasminogen activator.
Todd established the fibrin slide technique to detect fibrinoly­
tic activity histologically in tissues by adoption of the fibrin plate 
method of Astrup and Lassen (Todd, 1958a; Astrup, et al., 1952b; Lassen, 
1953c). He further investigated practially all the organs within the body 
and found that the fibrinolytic activity within the tissues after 30 min­
utes incubation on fibrin slides was related only to veins and venules, 
except in the lung where it was related to the pulmonary artery (Lassen, 
1953). In arteries the activity was localized only in the vasa vasorum, 
none in the intima. The desquammous endothelial cell from venous intima 
also caused lysis areas on the fibrin slide, but the remaining under­
lying layers of the veins had no activity. By using ht-’ted and unheated 
fibrin plates, Todd also proved that the fibrinolytic activity within 
the active tissues was due to release of a "plasminogen activator" (Chak- 
rabarti, e^ al., 1963). Warren was, however, able to demonstrate lytic 
areas on fibrin plates caused by endothelial strips from the pig ox and 
rat aortae after three to five hours incubation while those from the in­
ferior vena cavae showed activity after only one to two hours. Plasmin­
ogen activator in the arterial wall also was found to be related to the 
vasa vasorum possibly being derived from their endothelial cells. Kwaan 
induced clots in the femoral vein of the rat using thrombin, serum and
54
sodium morrhuate. Thrombin and serum clots lysed after four hours, but 
sodium morrhuate thrombi did not lyse until recanalization took place 
with the formation of new active endothelial cells. Sodium morrhuate 
caused endothelial damage which abolished its fibrinolytic activity.
Astrup performed a series of quantitative analysis of the plasminogen 
activator activity by measuring the activity of potassium thiocyanate 
extracts of individual tissue layers of the aorta and inferior vena cava 
in numerous subjects: humans, rats, rabbits, dogs, oxen, horses, pigs
and monkeys (Astrup, et al., 1963a; Albrechtsen, et al., 1959b; Coccheri,
£t al., 1961c). Celander's group measured plasminogen activator released 
from everted external jugular veins and femoral veins of the dog by 
assessing the amount of digestion of a plasminogen rich fibrin clot. They 
found that veins with a large caliber have more activity than smaller 
veins, and that the fibrinolytic activity was inhibited by epsilon amino 
caproicacid (Celander, et al., 1966a; Messer, et al., 1962b). Kwaan, in 
his report on fibrinolytic activity and its correlation to tissue repair, 
states that demonstrable activity was found to be related to the newly 
formed capillaries of the repairing granulation tissues (Kwaan, 1966).
His investigations included: implanted homologous plasma clot in rats,
active ulcerative colitis, human myocardial Infarction and finally experi­
mental liver cirrhosis in rats. Especially with the implanted plasma clot, 
a serial study was continued from two days to two months after implanta­
tion. In the initial state (within four days of implantation) when poly­
morphonuclear leukocytes and other acute inflammatory cells began to in­
filtrate, fibrinolytic activity and weak proteolytic activity were demon­
strated. After one week, further increase of plasminogen activator was
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found in capillary buds sprouting from the clot. After two weeks the 
implanted clot had disappeared but high plasminogen activator then de­
crease progressively and at four to six weeks the fibrinolytic activity 
was no longer found in all capillaries and a longer incubation time was 
required to induce areas of lysis. In experimentally induced cirrhosis 
of the rat liver, the fibrinolytic activity was also found to be associ­
ated with capillaries in the fibrotic area. Kwaan therefore suggested 
that the marked fibrinolytic activity is associated with young capil­
laries and appears to play a role in the process of tissue repair. From 
these observations and findings by other investigators, it can be con­
cluded that endothelial cells are possibly an important source of plasmin­
ogen activator both in blood and tissues.
Earnhardt and Riddle, using a fluorescent antibody technique, 
demonstrated the presence of plasminogen within eosinophilic granules 
of bone marrow cells. When the cells became mature the plasminogen con­
tent increased. Earnhardt and Riddle suggested the possibility that the 
eosinophilic cells of the peripheral blood are responsible for the trans­
port of plasminogen, when its needed, to the general circulation and the 
tissues (Eamhardt, et al., 1963).
Kunzer and Haberhausen demonstrated the presence of plasminogen 
activator in the stromata of the red blood cell hemolysate, although hemo­
globin showed no fibrinolytic activity (Kunzer, et al., 1963). They sug­
gested that erythrocytes might play a role in clot dissolution. That the 
red cell stroma does indeed contain plasminogen activator was later con­
firmed by Tyminski and Czestochowska (Ibid.). They also observed the 
presence of plasminogen and plasmin in this material.
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Both fibrinolytic enzymes and fibrinolytic inhibitors were ra­
ther definitely demonstrated within the formed elements of the blood.
There is still no information available concerning their definite roles 
in the fibrinolytic system. However, in various blood diseases changes 
of the blood fibrinolytic activity has been observed. Increased fibrin­
olytic activity has been reported both in acute and chronic leukemia 
(Fearnley, 1965).
In the lymphoma group which includes Hodgkin's disease, lympho­
sarcoma and reticulum cell sarcoma 20 percent of 125 cases studied showed 
increased fibrinolysis. The plasminogen level in both leukemia and lym­
phoma was lower than normal, an apparent consequence of increased fibrin­
olytic activity resulting in a using-up of plasminogen. The observation 
of increased fibrinolytic activity in both leukemia and patients is very 
interesting. Unfortunately, all the fibrinolytic determinations were 
done only in plasma. No data was reported on fibrinolytic enzyme within 
leukemic and lymphoma cells, with the exception perhaps of Rosenthal who 
mentioned the absence of fibrinolytic activity in suspension and extracts 
of the promyelocytic cells from patients with acute promyelocytic leukemia 
(Rosenthal, 1963).
It is worthwhile to point out that the vascular wall, plasma and 
formed elements of the circulating blood, are enriched with fibrinolytic 
enzymes. Whether these represent the sites of storage or of actual syn­
thesis of the fibrinolytic enzymes has not yet been elucidated.
From various observations, it is apparent that both the autonomic 
nervous system and physiologic reflex mechanisms participate significantly 
in the plasminogen activator release. Cholinergic vasodilation is probably
D/
one of these neurogenic mechanisms. However, other unexplained mechan­
isms also seem to participate in activator release, namely electroshock 
and atropine induced fibrinolysis. This certainly requires further in­
vestigation.
The fibrinolytic system has an apparent inter-relationship not to one 
individual organ but to several different organs. Although the evidence 
for this deduction was mostly in pathologic conditions, the important con­
clusion that possibly the regulation mechanism of the fibrinolytic system 
under hypoxia stands firm and challenging. Abnormal function in many 
organs (under hypoxia, chronic or acute exposure to CO) seems to induce 
an imbalance of fibrinolytic enzyme system. Increased fibrinolytic acti­
vity under hypoxia was observed in numerous pathological conditions.
However, there are still many abnormal physical states involving the 
function of a multitude of organs under hypoxic conditions where there 
is no information on their relation to the fibrinolytic system.
Plasminogen and antiplasmin were found to fluctuate insignifi­
cantly during changes of fibrinolytic activity. In contrast, the plasmin­
ogen activator was clearly demonstrated to be associated with and appeared 
to be responsible for changes of fibrinolytic activity in both increased 
and decreased fibrinolytic states. This indicates that the plasminogen 
activator is probably the most important variable component in the fibrin­
olytic enzyme system. Generally speaking, the regulation of any metabolic 
pathway is known to be primarily effected by so-called "key enzymatic 
steps." The regulation is found to be in their enzymes ("key enzymes") 
whose activities are variable, thus maintaining that pathway in a balance 
state (Anderson, 1973). This could also apply for the fibrinolytic system.
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Plasminogen activator would fit beautifully into the concept of "key 
enzyme" as the main regulator of the total fibrinolytic system in the 
body, although the modulating factors are not yet well-defined. Plas­
minogen activator is found in practically all organs and tissues. This 
indicates the significance of the plasminogen activator, although its 
function in tissues is not yet known. Our hope is to obtain enough in­
formation to further the understanding of the basic relationship be­
tween hypoxic conditions either chronic or acute and fibrinolytic enzyme 
system, and in addition, the function of this fibrinolytic enzyme sys­
tem and relation to the coronary thrombosis.
Finally, it is hoped that the results obtained in the investiga­
tions to be reported may make a significant contribution to widening 
the knowledge and increasing the understanding of the hypoxia and its 
effects on fibrinolytic enzyme system within the body.
CHAPTER III 
EQUIPMENT, METHODS AND PROCEDURE
3.1 Animals ; Male New Zealand while rabbits (3.50-4.50 kgm) were 
maintained on a diet of Purina Laboratory Chow and water. The water 
was treated with subclinical dose of Purina tylosin tartrate (0,5 gm 
per gallon) to decrease incidence of respiratory infection commonly 
associated with laboratory animals.
3.2 Exposure Chambers ; Air-tight environmental chambers were used 
in which rabbit cages could be placed and through which gas mixtures 
could be passed. One of the chambers was of simple flow-through de­
sign which allowed for the maintenance of a normal air environment
at one atmosphere. The other chambers were incorporated into a closed 
environmental system, each having the* dimensions of 5 x 3^ x 3 ft.
Each chamber was operated at a slight negative pressure and was capable of 
holding four metabolic rabbit cages without crowding. Oil-free com­
pressed air and CO were premixed in a laboratory fabricated mixing cham­
ber containing small glass beads, and this CO/air mixture was diffused 
throughout the chambers through small holes in plastic pipe within each 
chamber. The system was maintained with physical constants: (a) the
constant temperature, (b) the constant positive pressure, (c) the con­
stant negative pressure system which brings the effluent gases from the
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FIGURE 2. Sketch indicating principles of operation 
of the exposure chambers, measurement of 
CO concentrations, calibration and re­
cording system.
t o g g l e  v a l v e s PRE S S  URE REGULATORS
k-nûuJH CONC.0F - < ' #  V

















E X PO SU R E  CHAMBERS
62
animal chamber to the exhaust tunnel, (d) the constant humidity. The 
tanks were balanced to maintain the 50 ppm CO level for 24 hrs. Carbon 
monoxide was measured by Beckman Model 315 A(L) infrared gas analyzer 
(41-inch cell length) constantly (constant concentration of 50 ppm) to 
each chamber. Commercial grade CO having 98 per cent purity was pur­
chased from the Matheson Scientific Co. and used as the exposure gas. 
Positive CO pressure was maintained by a single stage regulator.
The CO source tank was connected to a gas mixing chamber by a 
line from a Mine Safety Appliance single stage regulator on the tanks.
The compressed air was connected from the compressed air source to the 
gas mixing chamber through a separate aperture while another aperture 
permitted the gas sampling line to exit from the chamber for quantita­
tive analysis. (Figure 2.)
The CO infrared analyzer could be adjusted to monitor the expo­
sure chamber either continuously or, by manual adjustment, intermittently. 
During the night and early morning hours the exposure chamber was moni­
tored on a continuous basis. Prior to exposure, the analyzer was cali­
brated with 100 percent nitrogen and then with CO of known concentra­
tion. Following calibration of the analyzer, the mixture of CO compressed 
air within the exposure chamber could be adjusted for proper proportions 
to meet the desired CO concentration. Once the calibration was completed, 
the desired CO concentration could be maintained within ±5 ppm using 
this exposure arrangement. Carboxyhemoglobin and hemoglobin concentra­
tions were measured by utilizing the IL-182 CO-oximeter.
This procedure involved the combination of a sensitive and accur­
ate absorption spectrophotometer with an analog computer. Three precision
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interference filters were used as monochromators to measure the blood 
oxygen, carbon monoxide and hemoglobin concentrations. (Figure 3)
Twelve rabbits selected at random were maintained in chambers 
where they were exposed to CO of 50 ppm for twenty-four hours for eight 
weeks. The other group of six rabbits were maintained in chambers that 
had the same environmental conditions but no CO passed through. Only 
normal oil-free air was used as control. Twice a week for eight week 
period blood samples were drawn from the lateral ear vein of rabbits.
Three to four ml of blood were withdrawn into a vacutainer tube (Becton- 
Dickinson) which contained the anticoagulant and prevented oxygenation 
of the blood samples. The vacutainer tubes were tilted gently to 
achieve adequate mixing. The skin overlaying the vein was cleaned with 
alcohol or ether.
Freshly drawn blood samples were utilized for hemoglobin, carboxy­
hemoglobin, o x y h e m o g l o b i n  a n d  b l o o d  fibrinolytic activity 
which was measured by whole blood clot lysis, a modified Feamley tech­
nique, euglobulin lysis, fibrin plate, caseinolytic assay, fibrinolysis, 
serum fibrin/fibrinogen degradation products.
At the end of the 8th week 12 exposed and 6 control rabbits were 
bled by cardiac puncture and sacrificed by anesthetizing with diethyl 
ether. The thoracic cavity was opened, and the heart, thoracic aorta 
were removed and immediately placed in 10% formaline solution for histo­
logical examinations.
The instrument processes and analyzes fresh drawn blood samples 
automatically. A peristaltic pump anaerobically draws up, hemolyzes 
and moves the sample into the measuring cuvette. Applying the principles
FIGURE 3a. Profiles of mean values of COHb, Hb, O 2 .
Twelve rabbits (test) that received 50 
ppm CO continuously for eight weeks.
b. Profiles of mean values of COHb, Hb, 0^ 
of six rabbits (control) that maintained 
under the same environmental condition 

























of the Beer’s Equation in absorption spectroscopy, the instrument simul­
taneously monitors each blood sample at three carefully selected wave­
lengths in the green region of the spectrum. (Figure 4)
3.3 Measurement of deoxygenated (or reduced) hemoglobin, oxy- 
hemoglobin and carboxyhemoglobin;
As deoxygenated (or "reduced") hemoglobin, oxyhemoglobin and 
carboxyhemoglobin each have a unique, but overlapping absorption spec­
trum, at any given wavelength the total absorbance is a summation of the 
absorbance of all three species. (Figure 5)
Absorbance measurements were made at wavelengths where the absorp­
tivity of two or more of the species were equal or isosbestic. From the 
absorbance at 548 nanometers (nm) changes in absorbance were related to 
changes in total hemoglobin concentration. A change of absorbance at 
568 nm compared to the absorbance at 548 nm indicated a change in the 
relative concentration of COHb. A change at 578 nm relative to 548 nm 
indicated a change in the relative concentration of oxyhemoglobin. Thus, 
information was obtained when entered into an electronic computational 
matrix, allowed presentation of the percent oxyhemoglobin (HbO^), and 
the total hemoglobin (Hb) species concentrations presented in digital 
form COHb and Hb were calculated by solving the following simultaneous 
equations.
1) Aĵ  = aj Ĥbr bcHbr + a^Hb02bcHb02 + HbCO bcHbCO
2) A 2  = a2 llbr bcHbr + a2Hb02 bcHbOg + a2HbC0 bcHbCO
3) Ag = a^Hbr bcHbr + a^HbOg bcHbOg + a^HbCO bcHbCO
"a " represents the absorbance (log I^/I) measured at a given wave­
length; "a" is the absorptivity of each species at that wavelength, and
FIGURE 4. Sketch Indicating Principle of Operation 
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FIGURE 5. Hemoglobin. Spectra. Hemoglobin CarboxyhemogloDin 
and Oxyhemoglobin each have a unique, but over­
lapping absorption spectrum; at any given wave­
length the total absorbance is a summation of the 
absorbance of all three species.
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"b" is the sample path length. 1 = 548 nm, 2 = 568 nm, and 3 = 578 nm. 
Equations used to determine percent saturation:
Hb = [Hbr] + [HbO„l + [Hbccj2-
[HbO ]
% H b O -------------- ----------- X 100
[Hbr] + [HbOg] + [HbCO]
[HbCOj
%HbCO = ------------------------ X 100
[Hbr] + [HbO^l + [HbCO]
The Hb species which were measured were deoxygenated, oxygenated, and 
carboxyhemoglobin. (Table 1 and 2)
3.3.1 Spectrophotometric Determination of Carboxyhemoglobin 
and Oxyhemoglobin Saturations in Whole Blood:
Freshly drawn blood samples were used in the assay. .02 ml of 
citrated whole blood was added to 5 ml of 0.1 M ammonium hydroxide. The 
Beckman DB Spectrophotometer was adjusted at 600 X with 0.1 M ammonium
hydroxide solution then read the optical density of the sample solutions
at visible range: (wave lengths: 541, 561, 573, 577, 597).
a) Percent carboxyhemoglobin saturation:
A. 577 my
A, 561 m
b) Percent oxyhemoglobin saturation:
A, 541 my
A^ 561 my " ® ’°2^
The results were read from the standard curve shown in Figure 6. The 
results obtained spectrophotometrically were similar to the results obtained
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TABLE 1
KAJJûXi.a jLAfuaùu xiuwxiwuuuSu xu ou ppm CO xOR o wüiuCS 
(MEAN VALUES OF 8 RABBITS PERCENT OF SATURATIONS OF 
Hb, Og AND COHb FOR EACH WEEK)
Hb, COHb and 0^ Mean Values of Percent 
Saturations Per Week
No. of Weeks o„% Hb% COHb%
0
L
91 - 95.00* 10 - 12** 4.80
1 87.70 11.80 17.60
2 78.10 13.00 19.00
3 75.88 12.65 20.00
4 75.44 12.66 22.50
5 72.50 12.67 24.83
6 72.51 12.74 27.88
7 72.60 12.54 29.94
8 72.71 12.74 30.91
*Normal value; Henson, M., e^ , J. Avait M., 18:149 (1947).




6 CONTROL RABBITS (NON-EXPOSED) MAINTAINED IN ENVIRONMENTAL 
CHAMBERS FOR 8 WEEKS UNDER THE SAME ENVIRONMENTAL 
CONDITION AS EXPOSED RABBITS BUT DID NOT 
RECEIVE CO
(MEAN VALUES OF 6 RABBITS PERCENT SATURATIONS OF 
Hb, Og, AND COHb FOR EACH WEEK)
Hb, COHb and 0^ Mean Values of Percent 
Saturations Per Week
No. of Weeks 0.% Hb% COHb%
0
— /
91 - 95.00* 10 - 12** 4.80
1 95. 00 11.75 5.20
2 89.75 11.62 5.55
3 89.00 12.15 5.20
4 88.50 12.05 5.00
5 89.80 11.85 5.05
6 83.65 12.60 6.70
7 83.55 11.95 7.00
8 83.00 11.85 7.45
*Nonnal values: Henson, M., et al., J. Avait. M. 18:149 (1947).
**Normal values: Wintrobe, M. M., and Schumacher, H. B., Am. J. Anat.
58: 313 (1935).
N
FIGURE 6. Standard Graph for Hemoglobin and Oxyhemo­
globin determination from spectrophotometric 
readings.
üxy-hemoglobin









from the CO-oximeter. (Figure 3)
3.4 Euglobulin lysis time:
Euglobulin lysis time (ELT), as described by von Kaulla and 
Schulz (1958): The euglobulin fraction containing fibrinogen, activator
and plasminogen, but no antiplasmin, is precipitated by lowering the 
pH and ionic strength. After redissolving the precipitate and clotting 
the fibrinogen with thrombin, the clot dissolves spontaneously. This 
lysis is the result of activation of the plasminogen in the euglobulin 
fraction by the activator. The resulting lysis time reflects the degree 
of activator activity present. The technique is as follows:
3.4.1 ELT (Modified Methhd):
(1) Plasma is separated by centrifugation at 4°C from citrated 
whole blood immediately on collection.
(2) Acidification to pH 5.9 may be achieved by either (a) adding 
9.5 ml. of acidified water (made in large bulk in the ratio of 18.68 ml. 
of distilled water to 0.32 ml. of 1 percent acetic acid) to 0.5 ml. of 
plasma; or (b) by adding 15.0 ml. of distilled water to 1.0 ml. of plas­
ma and bubbling a stream of carbon dioxide through this mixture.
(3) After standing at 4°C for 15 minutes, the euglobulin preci­
pitate is collected by centrifugation at 2000 rpm for 5 minutes at 4°C.
(4) The precipitate is redissolved in 0.5 ml. of bovine thrombin 
solution (10 NIH units per ml.).
(5) The clot is incubated in a water bath at 37°C and observed 
at frequent intervals for lysis.
Results: Figure^7 gives the representative example of the trend
of the ELT of exposed and control groups. There is an increase of fibrin-
FIGURE 7. Decrease in ELT in blood of rabbits 
that were exposed to 50 ppm CO con­






H o . of Weeks
00
TABLE 3
ELT IN NORMAL-CONTROL RABBITS(48-ELT IN 6 RABBITS, BODY WT. 3.5-4.5Kgm
ALL MALE MEAN 123. S.D. 30)
1 2 3 4
No. ELT (min) No. ELT (min) No. ELT (min) No. ELT (min)
1 104 13 210 25 150 37 110
2 133 14 156 26 125 38 140
3 116 15 120 27 140 39 200
4 158 16 110 28 200 40 160
5 120 17 127 29 180 41 140
6 170 18 160 30 190 42 180
7 141 19 180 31 156 43 210
8 210 20 190 32 135 44 140
9 149 21 200 33 180 45 110
10 120 22 210 34 190 46 130
11 140 23 130 35 160 47 145
12 156 24 156 36 140 48 220
VO
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olytic activity after the first week of exposure of CO of 50 ppm. Increase 
in fibrinolytic activity was related to the concentration of the CO and 
the time period that CO was exposed.
3.5 Whole Blood Clotting Time;
The technique of whole blood clotting described by Lee and White 
(1913) was the first attempt at a standardized coagulation assay. The 
recalcification time was a somewhat more sophisticated technique described 
by Howell (1916) to detect clotting abnormalities. When the significance 
of the surface activation was realized, it became obvious that the re­
calcification time was influenced by contact activation. For this reason, 
several researchers have attempted to make the test more sensitive by re­
ducing surface activation through the use of either siliconized glass or 
plasticware. Several improved techniques for improved standardization 
of the test were developed. In most instances this was accomplished by 
introducing glass beads and agents with similar surface characteristics 
to insure consistent maximal surface activation.
The activation of Hageman factor takes place in the presence of 
substances not present in the vascular system, e.g. silica particles. 
Activation is also achieved by fatty acids, ellagic acid and collagen 
(Margolis 1957a; Waaler 1959b; Nossel, 1964c; Hoak, et al., 1967d).
Principle of the method: Blood was collected from the ear of the
rabbits. One ml of blood was introduced into each of 3 prewarmed glass 
tubes and the tubes were placed in the 37°C water bath. The tube one was 
tilted every 30 seconds until flow of blood stops, leaving the tube two 
and three untouched. Next tube two was tilted every 30 seconds until 
completely clotted. At that point, the tilting of tube three was started.
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The end point for the test was the time when the blood was clotted in 
tube three. Clotting time was the total time elapsed from the start of 
withdrawal of the blood from the vein until completion of clotting in 
tube 3.
Results: Figure 8 shows the results of whole blood clot time
of eight week mean value of test and control groups. The t-test using 
.the eight week mean values of both the test and control groups gave a 
level of significance of p > 0.025 which is a significant difference.
3.6 The whole blood lysis time:
Reagents for the assay - phosphate buffer pH 7.4
NagHPO^ - 9.47 gm in one liter 
K HgPO^ - 3.02 gm in 250 ml 
Procedure: Ten test tubes were needed. 1.5 ml of blood were 
taken with siliconized syringe and was added to 5 ml of ice cold buffer 
and then kept in ice.
Tube No. 1 2 3 4 5 6 7 8 9 10
Blood and 
Buffer 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 1.1 ml
Buffer
Solution 1.7 1.6 1.5 1.4 1.3 1.2 1.1 1 0.9 0.8 ml
Thrombin
Solution 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 ml
(1) In the first tube put 0.2 ml of the mixture of blood and
buffer. In the second put 0.3 ml., in the third 0.4 ml. and so on till 
the tenth tube put 1.1 ml. of the mixture of blood and buffer as in the 
above mentioned table.
FIGURE 8. Clotting time is increased in the blood 
of exposed rabbits (50 ppm CO) as com­













(2) The buffer was added to each of these tubes and made up to 
1.9 ml. in each i.e. in the first tube put 1.7 ml., in the second 1.6 ml., 
in the third put 1.5 ml. and so on till the tenth tube in which 0.8 ml. of 
buffer was added.
(3) Thrombin solution was prepared by using Parke-Davis.
(4) To each test tube 5 NIH of thrombin was added.
(5) Each tube was gently shaken and left in ice for 15 minutes 
then transferred to water bath at 37°C for 10 minutes. The tube was ro­
tated gently in order to take the clot off the wall of the tube. The 
tubes were left in water bath for 12 hours and read the end point which 
was complete lysis. Then read again after 24 hours.
Results: In the control group 6 subjects (rabbits) blood were
examined to eight week period. No fibrinolytic activity could be detected 
as evidenced by absence of lysing in any of the tubes after incubation 
for 24 hours at 37°C.
In the test subjects, 12 rabbits’ blood were examined for fi­
brinolytic activity. After incubation at 37°C for 12 hours more than 
half of the tubes that showed lysis. This ranged from 6-10 with a mean 
8.2±1.6. After incubation for 24 hours, the tubes that showed lysis 
ranged from 8-10 with mean of 9.6±.4. The t-test showed significant 
variation between the control group and the test group. There was a 
significant increase in fibrinolytic activity in the blood of exposed 
rabbits.
3.7 Platelet Morphology:
Blood was collected from the ear of rabbits as described before 
into a chemically clean dry syringe; care was taken to avoid admixture of
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air bubbles. The blood was then rapidly added to test tubes containing 
the following anticoagulant solutions; 14 per cent magnesium sulfate,
3.2 per cent sodium citrate, 1.6 per cent potassium oxalate, 4 per 
cent ammonium oxalate, 0.8 per cent potassium axalate with 1.2 per cent 
ammonium oxalate, 2 per cent sodium oxalate, 0.85 per cent sodium Chloride 
containing enough heparin to provide 100 gamma of heparin (the Upjohn 
Company, Kalamazoo, Michigan) for each cubic centimeter of blood added. 
Dilutions of 10:1, 1:1, and 1:10 and 1:100 of blood to anticoagulant 
solution were made.
From the 1:1 dilutions platelet-rich plasma was removed after 
one half-hour period of sedimentation or after slow centrifugation, with 
the exception of the ammonium oxalate solutions which were hemolytic.
The anticoagulants used did not affect the pH of the blood significantly 
in 1:1 dilutions. As measured in the test tube by the glass electrode 
the pH varied from pH 7.10 to 7.45, and was usually between 7.15 and 7.50.
A small drop of blood or plasma was transferred to a slide and 
allowed to spread between slide and coverslip. The coverslip was rimmed 
with vaseline and the preparation was studied with a 97X dark contrast 
phase oil immersion objective. The 1:100 dilutions of blood to anticoagu­
lant were also examined in a counting chamber with a 43X dark phase 
contrast objective. The slides were examined from 30 minutes to 12 hours 
after their preparation.
3.8 Platelet Counting;
Blood was collected in a 10 ml siliconed syringe, through a 20- 
gauge sharp needle as described before. If bubbling occurred the blood 
was discarded and new needles and syringes used. One ml. of blood was
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drawn into the syringe and the needle was removed. A few drops of blood 
were placed on a siliconed water glass to facilitate filling of the sili­
coned red blood cell hemocytometer pipettes. The 20-gauge needle was 
inserted into the vein, 1 to 2 ml of blood was allowed to flow directly 
into a siliconed test tube, 10 x 75 imp ,and the pipettes were filled 
from the test tube. The blood was drawn to the 1.0 mark and then diluted 
with one percent ammonium oxalate. All of the platelets in 5 blocks of 
small square were counted after 15 minutes of settling, using a phase 
microscope, dark contrast 43X objective, long working distant phase con­
denser, and a counting chamber with an optically flat bottom. Both sides 
of the chamber were counted, and the total number counted was multiplied 
by 2500 to give the number of platelets per cu. mm.
Results: Figure 9 shows the results of platelet count in experi­
mental and control rabbits. The t-test, the eight week mean values of 
both the test and control groups, gave a level of significance of p > .015 
which is a significant difference.
3.9 Isolation of Transglutaminase (Factor XIII) Free of Fibrinogen 
for Fibrin Plate Preparations:
Pooled human plasma from normal human donors was anticoagulated 
1 to 9 with 4% citrate for Cohn Fractionation. The method was used to 
purify the fibrinogen from human plasma proteins. The method is equally 
well applicable to human as rabbit plasma. Since proteins are, as a rule, 
more stable.
3.9.1 Cohn Fractionation;
The method was used to purify the fibrinogen from plasma proteins. 
The method was equally applicable to human as well as rabbit plasma.
FIGURE 9.. Platelet quantity is reduced in the blood of 
exposed rabbits compared with the non-exposed 
rabbit’s blood. By comparing the decrease of 
number of platelets in exposed rabbits blood 
with the control (non-exposed rabbits) blood, 
shows evidence of vascular platelet consump­
tion or platelet destruction in the circula­
tion of exposed rabbits blood.
Control 
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Since proteins are, as a rule, more stable in the solid state, and disso­
lution of fibrinogen in the presence of prothrombin had to be involved 
undue risks, in purification of fibrinogen as far as possible by extract­
ing the contaminants.
Dissociation of the protein complexes in fraction I with simultaneous 
quantitative separation of the components was, however, difficult to 
achieve by simple extraction with buffer solutions of varying pH and ionic 
strength. Preliminary fractionations nevertheless showed that separation 
was highly effective when extraction was performed in the presence of gly­
cine. Glycine in high concentration enhanced the salting-out effect on 
the fibrinogen, where the salting-in on the contaminating proteins were 
considerable. Under these conditions, 95% of the fibrinogen was recovered 
in the residue (fraction I-O), whereas the major part of the impurities 
were extracted. With this procedure, the coagulability of the protein in­
creased from 40 to 50% in fraction I to 85 to 90% in fraction I-O.
Fractionation procedure: At first plasma centrifuged 4000 revo­
lutions per minute (RPM) for 30 minutes by Sorvall Model RC-3 centrifuge.
The small amount of red cell precipitate was removed from the plasma.
The fractionation was done in the cold bath (Fisher Serological Bath).
Ethanol chilled (0°C) was added to the plasma (initial concentration 
of ethanol 53% v/v to the final concentration of 8% v/v). pH was adjusted 
to 7.4 by adding 0.8 M sodium acetate. Small motor stirrer, was stirring 
constantly during the addition of ethanol one and half hour of time given 
for the total volume of ethanol to be added. During the addition of 
ethanol pH was checked frequently in order to be sure that pH of the 
plasma was kept around 7.2 (pH was adjusted with 7% acetic acid). During
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the addition of ethanol the temperature of the system was kept below O'̂ C 
close to -2°C so that the system was maintained close to the freezing 
point. The final temperature was -3°C. After one and half hours, the 
reaction mixture was centrifuged at 2500 RPM for 20 minutes at -3°C.
The supernatant which was rich in plasminogen was frozen at -20 and 
saved for further purification. Precipitate was washed with chilled 
amino-acid citrate buffer pH 6 and 7 (75 g. glycine, 65 ml absolute 
ethanol, and .055 M sodium citrate made up to 1 liter and pH was ad­
justed with 6N hydrochloric acid).
First wash was with the pH 6 buffer (used 1/4 of the original 
volume of the plasma). The buffer was added with caution and constant 
stirring for 1 hour at -3°C was done. The mixture was centrifuged 
at 2500 RPM for 20 minutes and the supernatant was discarded.
Second wash was with the pH 7 buffer (used 1/4 of the original 
volume of the plasma). The second buffer was added with caution and 
constant stirring for 1 hour at -3°C was made. The mixture was centri­
fuged at 2500 RPM for 20 minutes and the supernatant was discarded.
After second wash the pellet was dissolved in .05 M sodium citrate 
buffer pH 6.35 (the vol. of the buffer was 1/8 the original vol. of 
plasma) and kept at 30°C for 30 minutes, then diluted to final concen­
tration of 1.5% with .05 M sodium citrate buffer. This diluted Cohn 
Fraction I-O fibrinogen was further purified by column chromatography.
Chromatography: Cohn Fraction I-O solution containing 250 mg
of protein were diluted to 10 ml with "starting buffer" and dialyzed in 
the cold room, 4°C for 48 to 72 hours against four changes, approximately 
750 ml each, of the same buffer.
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"Starting buffer" (pH 8.6) was .005 M in H^PO^ and 0.029 M in 
Tris (hydroxymcthyl)—aniiriû-ïïiêthariê(Tris). The final buffer was 0.5 M 
in both HgPO^ and Tris, and had a pH of 4.1. After dialysis the Cohn 
Fraction I-O sample was placed on a 2.2 cm x 30 cm column of diethyl- 
aminoethyl) (DEAE) cellulose equilibrated with starting buffer. The 
DEAE cellulose, (Scheicher and Schuell, Inc.) equilibrated with starting 
buffer. The chromatography was done at 4°C, essentially by the method 
of Finlayson (1963). A compound concave elution gradient was obtained 
with a nine-chambered gradient elution device ("Varigrad") of the type 
described by Peterson (1958). Solutions placed in the chambers consisted 
of various amounts of final buffer diluted to 220 ml with starting buffer. 
The volumes per cent of final buffer in successive chambers were 0, 1.6, 
2.0, 9.0, 9.0, 20, 20, 100, and 100. A flow rate of 36 ml per hour was 
used and 8-ml fractions were collected (Figure 10) . The fractions 
were read at 280 mp in a Beckman DB spectrophotometer. Fractions con­
taining pure fibrinogen were pooled and dialyzed against .05 M sodium 
citrate solution pH 6.3 then lyophilized and the purity of the fibrin­
ogen subfraction was checked by 6% polyacrylamide gel electrophoresis 
and immunoelectrophoresis. This concentrated chromatographic subfraction 
was found to be contaminated with Factor XIII. Rechromatography of this 
fibrinogen subfraction was done on a column of Whatman DE-23 (diethyl- 
aminoethyl cellulose) from W. and R. Balson Ltd. England.
Same Tris-phosphate buffer system with compound concave elution 
gradient was used. This rechromatographed fibrinogen subfraction showed 
a single band on 6% polyacrylamide gel electrophoresis, immunoelectropho­
resis, and produced an acetic acid-soluble clot (Figure ll). The assay
FIGURE 10. Chromatography of fibrinogen (Cohn Fraction 
I-O). The profile shows the elution pattern 
of the fibrinogen of DEAE column in the cold 
room. Clottable protein is indicated by the 
dashed line.



















FIGURE 11. Immunoelectrophoresis of purified fibrinogen and rabbit 
anti-human fibrinogen antiserum. The wells were filled 
with 1 yl of fibrinogen at 10 mg per ml, and migration 
proceeded for 90 minutes at 250 volts, the troughs were 
filled with rabbit anti-human fibrinogen antiserum.




for transglutamirase did not show any transglutaminase activity. The 
fibrinogen subfraction free from Factor XIII was used for the fibrin 
plate preparations.
3.10 Preparation of Fibrin Plate:
The method described by Astrup and Müllertz was used for prepara­
tion of fibrin plates. Plasminogen rich fibrinogen, required for making 
fibrin plates, was prepared as follows: Human plasma was diluted with
0.5 vol. cold distilled water followed by 0.6 vol. of cold saturated 
ammonium sulfate, was slowly added in the cold room. The precipitate 
was redissolved in 0.5 vol. of saline and diluted with one vol. cold 
distilled water. The fibrinogen solution obtained was again precipitated 
in the cold room by slowly adding 0.6 vol. of cold saturated ammonium 
sulfate. The precipitate was next dissolved in 0.2 vol. distilled water, 
the pH was adjusted to 7.5 and the ionic strength to 0.3 or 0.4 by mea­
suring electrical conductivity in reference to a standard sodium chloride 
solution (sodium chloride in solution was assumed to be completely ionized) 
This fibrinogen-plasminogen solution which usually had a fibrinogen con­
centration between 1.5-1.8 gm percent was then stored frozen in 10-15 ml 
lots at -20°C.
Fibrin plate buffer, pH 7.75, ionic strength 0.15 was used to 
prepare the fibrinogen solution was made by mixing 20.62 gm sodium bar­
bital, 1350 ml distilled water, 500 ml 0.1 N HCl and 100 ml 0.1 salt solu­
tion (see below) in a 2000 ml vol. flask. The pH was adjusted to 7.75 
with 0.1 N HCl; and the solution made up to 2 litres with distilled water.
The salt solution was prepared by mixing 4.891 gm CaCl2*2H20,
2.787 gm MgCl2*6H20, 109.12 gm NaCl with distilled water to make a litre.
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Petri dishes (Optilux, 100x15 Falcon Plastics) were used to measure fi­
brinolytic activity. Unheated plates were prepared from the frozen 
fibrinogen which had been thawed slowly at room temperature, centrifuged 
at approximately 2000 G for thirty minutes and filtered through cotton 
wool. It was then diluted to a concentration of 0.1 percent and the ionic 
strength was adjusted to 0.15 with the "fibrin plate" buffer. Each petri- 
dish was filled with 6 ml of 0.1 percent fibrinogen solution and the 
fibrinogen was clotted by adding 0.2 ml thrombin solution (20 units per 
ml). The fibrinogen and the thrombin were carefully mixed by moving the 
plate in a horizontal plane with a perpendicular motion. Then the plate 
was left for one hour at room temperature in a perfectly horizontal posi­
tion. The plate was ready for use after incubation at 37°C for 20 minutes. 
Three hundredths ml of the unknown solution to be assayed for fibrinolytic 
activity was placed carefully on the surface of the fibrin plate. Each 
unknown is tested in duplicate or triplicate on the same plate. The 
plate was then incubated at 37°C for 16 to 18 hours. The diameter (D) 
of the lysis area (a clear round zone liquid surrounded by undigested 
fibrin) was measured in mm on two axis, perpendicular to each other. The 
product of the two diameters as the measure of the lysis area was ex­
pressed as sq. mm which, although not representing the actual lysis sur­
face, area, was an accepted way of expressing the results.
The fibrinogen solution was plasminogen-rich. Plasminogen co­
precipitates with fibrinogen, and its concentration will be directly 
related to the fibrinogen concentration. If plasminogen is present in 
the small volume of only 0.03 ml of the testing solution, it will be 
very little compared to the amount of plasminogen already contained
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within the fibrin plate. Consequently, plasminogen contamination of 
the solution to be tested has little effect on the results. The lysis 
area of the unheated fibrin plate, indirectly reflects but allows for 
measurement of the fibrinolytic activity.
To measure plasmin activity the heated plate (Lassen, 1953) was 
used. The heated plate was prepared in a manner similar to the unheated 
plate with the exception that a flat bottom, glass Petri dish was used. 
After 20 minutes incubation at 37°C, the plates were transferred into 
an oven with a temperature setting between 85-90°C, and were heated at 
this temperature for 30 minutes in order to denature all the plasminogen 
contained within the fibrin clot. After cooling down the room temperature, 
the heated fibrin plates were pre-incubated at 37°C before use. The solu­
tion to be tested were applied as previously described for unheated plates 
and the results were expressed in a similar fashion. Since all the 
plasminogen was denatured by the heat, any lysis area produced re­
presented the activity of plasmin or any other proteolytic enzyme which 
could digest fibrin.
3.10.1 Fibrin Plate Test (HYLAND)
Fibrin plate test is used to examine three components of the 
fibrinolytic system: available plasmin, active plasmin, and total plas­
minogen. Fibrin plate test is a sensitive and accurate indicator of 
fibrinolysis in plasma or plasma preparations.
The fibrin plate consists of a buffered agarose gel containing 
a homogeneous fibrin clot which is Factor XIII free and essentially free 
of plasminogen. Plasma or a plasma preparation placed in a well in the 
agar gel diffuses into the agar and lyses the fibrin clot, forming a clear
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reaction zone. The zone diameter is directly proportional to the log per­
cent concentration of available fibrinolytic enzyme in the sample. Each 
fibrin plate contains six wells: for both available plasmin and active
plasmin tests this is sufficient to determine activity in two samples; 
for the assay of total plasminogen one plate is used to prepare a refer­
ence curve and simultaneously to test one unknown sample.
3.10.2 Available Plasmin Test
(1) At first the plate was opened, and set in room temperature 
for 15 minutes.
(2) Added 0.5 ml of citrated test plasma to 0.05 ml of streptoki­
nase. Incubated 10 minutes at 37°C.
(3) Three wells of the fibrin plate were filled with the incubated 
mixture. Touched the tip of the capillary to the bottom of the well and 
allowed a drop of the solution to flow onto the base of the plate.
The capillary moved in a circular motion on the base plate until 
the bottom of the well was completely covered with solution, then con­
tinued filling the well until it is no longer visible when viewed from an 
angle.
(4) The top cover of the plate was replaced and incubated at 37°C 
for 8 hours.
(5) The diameter of the lysis zone was measured to the nearest 
0.1 mm. Then the diameters were averaged.
Results: Clear zone demonstrated the lysis area on unheated
fibrin plates induced by the rabbit plasma that exposed to CO of 50 ppm. 
The elevated fibrinolytic activity was measured after the second week of 
exposure. It appears as a clear, lysed, nearly round zone, surrounded
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by solid fibrin clot. Two perpendicular diameters (D) were read, in mm. 
Lysis areas were calculated by DxD. The size of each lysis area produced 
by plasma was converted in CTA units of urokinase by reading from the uro­
kinase standard curve. Each plasma sample was tested on five fibrin plates 
and applied in triplicate on each plate. Some variation in measurement 
was found both on the same fibrin plate and also between the different fi­
brin plate. The most obvious causes of variation in this measurement, 
that was, lysis areas which were not completely round. Theoretically, the 
lysis areas should be round as in Figure 14. Although the incubator was 
always carefully levelled, the lysis areas were not always completely 
round.
3.11 Purification of Plasminogen for the Caseinolvtic Assay;
Plasminogen was prepared from human plasma by affinity chroma­
tography on L-lysine-substituted sepharose. Thirty milligrams of plas­
minogen, with a specific activity of 100 caseinolytic units (Committee 
on Thronibolytic Agents) per milligram of nitrogen, were obtained from 
400 ml of plasma. This corresponds to over 200-fold purification from 
plasma. Plasminogen is the zymogen of the proteolytic enzyme plasmin 
(Alkjaersig, 1964a; Cuatrecases, et al., 1968b). The enzyme responsible 
for the dissolution of fibrin clots in the blood. In a continuing effort 
to resolve problems of activity, yield, reproducibility, homogeneity, 
stability, and solubility at physiological pH, dozens of methods have been 
used for the preparation of plasminogen (Remmert, et al.. 1949a; Kline, 
et , 1961b ; Slotta, et al., 1964c; Robbins, ejt al., 1965d; Chan, et al., 
1966e). In purification of plasminogen e-aminocaproic acid (e-ACA), and
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Inhibitor of plasminogen activation to plasmin by covalently binding the 
a-amino group of L-lysine to sepharose. Preparation of plasminogen by 
affinity chromatography, is an attractive alternative to the multistep 
procedures used before.
Agarose (Sepharose 4B, Pharmacia) was activated with cyanogen 
bromide (Cuatrecasas, et al., 1968). To a 150-ml suspension (0.1 M 
NaHCOg buffer, pH 8.9), containing 100 ml of activated agarose, 20.0 g 
of L-lysine monohydrochloride was added, titrated to pH 8.9 in 50 ml 
of water and slurry was stirred for 24 hours at 4°C. The amount of 
lysine bound to the agarose was 55 micromole (p mole) per milliliter 
of settled agarose, determined by Deutsch. If one assumes the molecular 
weight of plasminogen is 81,000 then each ml of settled lysin-sepharose 
could theoretically bind about 4 g of plasminogen provided that all the 
lysine molecules joined to the sepharose were available for plasminogen 
binding and a 1:1 stoichiometry exists between enzyme and inhibitor.
Agarose column (2.5 cm x 30 cm) containing 50 ml of degassed 
lysine-sepharose was equilibrated with 0.1 M phosphate buffer (pH 7.4).
A volume of 400 ml of plasma was diluted to 600 ml with water and passed 
through the lysine-sepharose column at 75 ml per hour and the column 
was next washed with 0.1 M phosphate (pH 7.4) at 175 ml per hour until 
the absorbancy at 280 nm was less than 0.01. The plasminogen was then 
eluted as a sharp peak with 0.2 M e-aminocaproic acid in 0.1 M phosphate 
buffers (pH 7.4) at 100 ml per hour (Figure 12). All of the steps in 
the procedure, up to this point were performed at 4°C, and .003 M EDTA 
(ethylene diamintetraacetate) was added to the phosphate buffer as well 
as to the plasma.
FIGURE 12. Affinity chromatography of a plasminogen
by elution of 0.2M e-aminocaproic acid with 
O.IM phosphate buffer pH 7.4. The dotted 
peak shows the caseinolytic assay of plas­
minogen activity. 














The E - a m i n o c a p r o i c  a c i d  was removed from the plasminogen in the 
cold, by dialyzing against buffer (.06 M Tris, 0.09 M NaCl, 0.02 M Lysine) 
pH 8.9 overnight.
Plasminogen was freeze-dried and stored at -20°C. Plasminogen 
activity was measured by a standard caseinolytic assay suggested by the 
National Heart Institute's Committee on Thrombolytic Agents (CTA), 
Subcommittee for standardization with the specific activity expressed 
in CTA casein units per optical density unit. When 250 plough units of 
urokinase were used for activation of plasminogen to plasmin and when 
the plasminogen concentration was measured at 280 nm, the affinity chrom­
atography preparation had an average specific activity of 10 CTA units 
per absorbency unit (100 CTA units per ml of nitrogen) with no detectable 
spontaneous plasmin activity under the condition of the assay.
3.11.1 Caseinolytic Assay
0.3 ml of sample solution (plasma) was added to 1 ml plasminogen 
solution (8.5 CTA units/ml). The tubes were incubated for 10 minutes at 
37°C then 2.5 ml of 1.4% a-casein solution was added. After 2 minutes 
and 32 minutes incubation, respectively a 2 ml aliquot was removed and 
added to 3 ml of 0.5 M  perchloric acid, and the content was mixed gently 
for a few seconds. The precipitates were left at room temperature for 
30 minutes. The perchloric acid precipitates were removed by filtration 
(Munktell paper No. 00) into tubes for optical density (OD) measurements. 
The optical densities of the filtrates were read at 275 my. The differ­
ence in OD between the 30 minutes and zero time samples was the activation 
of plasminogen by the sample solution.
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Results:
The t-tests were used as a test for significance between eight 
week mean values of both the test and control groups. The results of these 
tests were highly significant with P > .001.
3.12 Standard Urokinase Curve:
A series of urokinase dilutions was prepared (1, 2, 3, 4 and 5 
CTA unit/ml gelatin buffer. One ml aliquots of each urokinase (UK) dilution 
were mixed with 1 ml plasminogen solution and 0.5 ml buffer. A blank 
was made by substituting 1 ml gelatin buffer for the UK. The tubes 
were incubated for 10 minutes at 37°C then 2.5 ml of 1.4% a-easein 
solution was added. After 2 minutes and 32 minutes incubation, respec­
tively, a 2 ml aliquot was removed and added to 3 ml of 0.5 M perchloric 
acid. The tubes were treated exactly as the caseinolytic assay of plas­
min or plasminogen. The blank value, representing spontaneous plasmin 
activity in the plasminogen preparation, were subtracted from the reading
obtained in the tubes containing urokinase. The standard curve and the
mean from 15 assays are shown (Figure 13).
Reagents :
(1) Gelatin buffer: 10 g purified calfskin gelatin (Eastman
Organic Chemicals, Rochester, N.Y.) dissolved in 1 litre 
of phosphate, or tris, or Tes buffer, placed in a boiling 
water bath for 1 hour or until the gelatin was dissolved 
and filtered, and kept frozen in small portions.
(2) Perchloric acid: (0.5 M) for caseinolytic assay: 42.8 ml
of 70% perchloric acid made up to 1 titre with distilled 
water.
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(3) Phosphate buffer: (0.06 M) - NaCl (0.09 M) buffer: 8.517 g
NagHPO^ (anhydrous) and 3.26 g sodium chloride dissolved
in 900 ml distilled water, pH adjusted to 7.5 with N hydro­
chloric acid and the volume made up to 1 litre.
(4) a-casein: 1.4 gram a-casein dissolved in 100 ml of tris-NaCl
buffer.
(5) Plasminogen: a solution containing 8.5 CTA plasminogen
units/ml buffer.
(6) TES-NaCl buffer (N-tris(hydroxymethyl)methyl-2-amino-ethane 
solfonic acid).
3.12.1 Urokinase determination in rabbit urine:
Urine (3-4 ml) is first dialyzed in cellulose dialysis tubing 
(Union Carbide O.D. 7 mm) against buffer saline pH 7.4 for 6-10 hours at 
4°C. The fibrin plate technique was used for measuring urokinase activity 
in dialyzed undiluted urine samples. The urokinase assay in each urine 
sample was run in triplicate.
After (3-4 ml.) were removed for measuring urokinase activity 
In fresh urine, the individual urine samples were pooled and kept refri­
gerated until 24 hours collection were completed. Urokinase activity was 
then measured in the 24-hour urine volume.
Figure 14 demonstrates the lysis area on unheated plates induced 
by urokinase in exposed and non-exposed rabbit urine, using the standard 
amount of 0.1 ml urine. It appears as a clear, lysed, nearly round zone, 
surrounded by solid fibrin clot. Two perpendicular diameters (D) are
read, in Figure in mm. Lysis areas were calculated by DxD. The size
*of each lysis area produced by ruine is converted in CTA units of uro-








FIGURE 13. Urokinase Standard Curve: Ordinate readings
are optical density at 275 mp. Abscissa 
readings are CTA units of urokinase used for 
activation of plasminogen to plasmin in the 
caseinolytic assay.
FIGURE 14. Example of lysis area produced on unheated 
fibrin plates by 0.1 ml dialyzed undiluted 
rabbit urine.
A - Control (non-exposed)
B - Test (Exposed to 50 ppm CO)
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kinase by reading from the urokinase standard curve.
The reproducibility of fibrin plate method. Table 4 illustrates 
the results of fibrinolytic activity— measured as lysis area— of 3 differ­
ent urine samples (A,B,C). Each urine sample was tested on five fibrin 
plates and applied in triplicate on each plate. Some variation in mea­
surement was found both on the same fibrin plate and also between the dif­
ferent fibrin plates. The range of the variation in the lysis area among 
3 observations taken from the mean on each fibrin plate, a total of 15 fi­
brin plates, was ± 5.0% to 24.2% (calculated from the range of 2 S.D.) 
with an average of ± 10.2%. The difference between lysis areas on the 
fibrin plates of ± 10.2% would have to be considered as insignificant.
The most obvious causes of variation in this measurement, that 
is, lysis areas which are not completely round. Theoretically, the 
lysis areas should be round as in Figure 14. Although the incubator is 
always carefully levelled, the lysis areas are not always completely 
round. However, the lysis areas on which the urokinase standard curve 
(to be described in the following section) is based, has the same range 
of variation as the ones caused by the urine samples.
3.12.2 Urokinase standard curve;
This was prepared as follows: Urokinase (calbiochem) was used
as a standard urokinase. This urokinase is serially diluted in 1% gly­
cerol buffer saline pH 7.4 (glycerol added to preserve urokinase activity 
after dilution) to arrive at urokinase concentrations from 0.025 to 60
CTA units/ml. Each concentration is applied in triplicate on untreated
2fibrin plates. The mean lysis area (mm ) produced by each urokinase 












Lysis Area (mm^) on Unheated Fibrin Plate




A 1 3 576 624 621 607 27 9.0
2 3 625 552 552 526 ± 42 14.6
3 3 625 650 624 633 ± 15 5.0
4 3 625 600 576 600 ± 24 8.0
5 3 529 600 600 576 ± 40 14.0
B 6 3 672 550 546 589 ± 70 24.2
7 3 600 552 575 575 ± 24 8.0
8 3 625 576 600 600 ± 24 8.0
9 3 576 600 529 568 ± 36 12.4
10 3 650 576 600 608 ± 38 12.4
C 11 3 546 513 483 514 ± 30 12.0
12 3 528 528 550 536 i 12 5.0
13 3 528 528 573 542 ± 24 9.0
14 3 525 480 480 500 ± 26 10.0
15 3 546 550 572 556 ± 14 5.0
h-*MM
Total Average 10.2
Variation of the lysis area induced by dialyzed undiluted normal rabbit urine on fibrin plate.
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on arithmetic graph paper against its concentration (CTA unit/ml). The 
resulting urokinase standard curve is shown in Figure .
Plasminogen rich fibrinogen prepared in our laboratory according 
to the method of Cohn was used to make the fibrin plates. Urokinase 
concentrations below .05 units per ml produced no clear-cut lysis areas. 
Concentrations above 80 units per ml produced the same lysis areas on 
the fibrin plates. Therefore, the sensitivity of the fibrin plates used 
in this study lay between .05 to 80 units per ml of reference urokinase. 
Undiluted urine samples which produce no lysis area (activity below .05 
unit per ml) are considered as having zero urokinase activity. Urine 
samples with an urokinase activity above 80 units per ml of standard 
urokinase had no actual readable values. From this observation, the 
question arose as to whether one should use the urokinase measurement 
in the diluted urine samples. Theoretically, this would permit reading 
in the upper range of values in cases where a particular urine sample 
exhibits high urokinase activity and fibrin plate insensitivity would 
ordinarily prevent determination of any value. In Figure 15 the re­
sults with urokinase activity measured in undiluted urine and in 1:2 
and 1:4 diluted urine of the same urine are illustrated (Figure 14).
Plasminogen determination: Plasminogen in plasma was first con­
verted to plasmin by a plasminogen activator and the resulting proteoly­
tic activity was measured by the procedure of Girolami, et al., 1967. 
This assay was performed as follows: 0.5 ml of citrated plasma (four
parts of blood to one part of 3.8 percent sodium citrate) was first ad­
justed to pH 2 with HCl and left at room temperature for 15-20 minutes 










500 6010 30 4020
Units of Urokinase (Calbiochem) 
per ml.
FIGURE 15. Urokinase Standard Curve.
Abscisca: Standard urokinase CTA units
per ml. g
Ordinate: The lysis area in mm on un­
heated fibrin plate.
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with NaOH and 0.1 phosphate buffer added to make a total volume of 
one ml. Streptokinase (Varidase) 1000 units or urokinase 100 CTA-units 
were added to activate the plasma plasminogen; and then 4 ml of 2.5 
percent casein (Hammersten. Vitamin-free) in 0,1 M phosphate buffer was 
immediately pipetted in and mixed well. A 2 ml aliquot was immediately 
taken and added to 5 ml of a 7 percent thrichloroacetic acid to stop 
the enzymatic action. This was zero time plasmin activity.
Another 2 ml aliquot was again withdrawn after one hour incu­
bation. The supernatant after cold centrifugation was used to determine 
the proteolytic activity at 275 millimicron in a Beckman D.B. spectro­
photometer. The difference between the readings at zero time and at 
one hour incubation would represent formed plasmin converted from plasmin­
ogen in the test solution. Activity was expressed as gamma of tyrosine 
was released and was read from the tyrosin standard curve. (Figure 16.)
3.13 Determination of Fibrinogen:
3.13.1 Spectrophotometric method;
Fibrinogen and fibrin were determined spectrophotometrically.
The fibrinogen content was calculated from the amount of fibrin formed 
under standard conditions by addition of bovine thrombin to a fibrinogen 
solution. For the coagulation and syneresis the method of Morrison, (1947) 
was used.
The coagulation was performed at pH 6.3510.05 and ionic strength 
0.15. The protein concentration in the coagulation mixture was between 
0.5 and 1.5 g/litre. The procedure is as follows; 1.0 ml of the fibrino­
gen solution (0.15-0.35) in 0.15 M sodium chloride was pipetted off into 








0.6 0.80 0.4 1.0
CTA Unit Plasminogen/m1
FIGURE 16. Plasminogen (at natural pH) assayed and 
a-casein used as a secondary substrate 
in caseinolytic assay.
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solution of pH 6.35 and ionic strength 0.15 were added. (The composition 
of this buffer: 0.005 M Na2HP0^•2 H 2 O , .010 M KHgPO^ and 0.12 M NaCl).
0.15 ml of a thrombin (bovine) solution containing 100 NIH units/ml was 
then added under mixing. The thrombin contained 100 NIH units/ml and 
was free of fibrinolytic enzymes.
The coagulation mixture was left standing at room temperature 
for two hours. The clot was then carefully poured on a small slick cloth 
(10x10 cm) with several underlying coarse filter papers and allowed to 
synerize completely. It was then immediately washed three times with 
0.15 M sodium chloride, after which the synerized clot was wound up on 
a glass rod. Drying of the clot had to be avoided, not to render the 
subsequent dissolution of the clot difficult.
The glass rod with the synerized clot was placed in a test tube 
with a ground-in stopper. Ten ml of 40% urea in 0.2 N sodium hydroxide 
were added, and the contents were mixed by whirling. After 60 minutes, 
when the clot was dissolved, 1.0 ml of 0.15 M  sodium chloride was added 
and the contents were carefully mixed. Within two to four hours after 
the addition of urea the extinction values were read in a Beckman spectro­
photometer, type DB, at 282 mp in a 1 cm cell against alkaline urea con­
taining the same amount of sodium chloride solution. Slit: about 0.3 mm.
17The extinction coefficients for bovine fibrin and fibrino­
gen in alkaline urea are 16.84 and 16.51 respectively. The intercept of 
the protein dilution curve with the ordinate is 0.01. The following 
formulas may then be used for the calculation of the fibrin content and 
the amount of fibrinogen corresponding to the fibrin.
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E - 0.01 ... . . . . .Q —  “ mg fibrin per ml original sample.
^0 150^^ ~ fibrinogen per ml original sample.
For fibrinogen determination in citrated plasma a somewhat modified pro­
cedure was used on account of the high buffering capacity of plasma. This
is briefly as follows; To 0.6 ml of plasma was added 0.4 ml of 0.15 M
sodium chloride and 2.0 ml phosphate buffer, pH 6.0, ionic strength 0.15. 
The pH value in the mixture will then be between 6.3 and 6.4 and the ionic 
strength about 0.15. In other respects the procedure was identical with 
that just described. As regards plasma fibrinogen determinations a com­
prehensive review of different methods has been given by Jacobsson (1955).
Determination of total protein in the fibrinogen preparations 
procedure was as follows; 1.0 ml of the fibrinogen solution (0.15-0.35%) 
in 0.15 M NaCl was pipetted off into a test tube and 10.0 ml of 40% urea
in 0.2 N NaOH were added. The extinction was read at 282 mp within two
to four hours after the addition of urea.
When calculating the protein content the extinction coefficient 
of bovine fibrinogen, 16.51 was used.
Thus,
^0 150^^ ~ protein per ml original sample.
Coagulability is the ratio of fibrinogen to total protein in the 
fibrinogen preparations.
% clottabllity = X 100
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3.13.2 Assay of Fibrinogen in Plasma:
(1) Blood samples were collected in heparin (dissolved in a 
minimal volume to avoid unnecessary dilution). The cells were centri­
fuged and the supernatant plasma was drawn off which was ready to assay.
(2) Plasma samples were diluted. Since the sensitivity of the 
assay was 2 yg per ml it was necessary to dilute the plasma approximately 
a thousand-fold. Three suitable dilutions were made for screening plasma 
fibrinogen levels were 1:500, 1:1000, 1:2000.
(3) One drop of each dilution was transferred to a previously 
marked circle on the glass test slide.
(4) The latex suspension was mixed by shaking the container vigor­
ously for a few moments and then one drop of latex was added to each 
plasma dilution on the test slide.
(5) Each of the plasma/latex mixtures was mixed by a disposable 
mixing rod and each pool of liquid was spreaded to fill the circle.
(6) The slide was racked gently for two minutes before looking 
for microscopic agglutination.
Readings of Results:
An agglutinated pattern in any position on the glass slide . 
indicated the presence of fibrinogen at a final concentration greater 
than 2 yg per ml in the plasma dilution in that position. A positive 
reaction in the 1:500 dilution was indicated a fibrinogen level in the 
original serum sample at a concentration in excess of 100 mg per 100 ml, 
in the 1:1000 dilution a level greater than 200 mg per 100 ml and in 
the 1:2000 dilution a level greater than 400 mg per 100 ml.
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3.13.3 Modified Micro-Kieldahl Method for Fibrinogen Determina­
tion;
The method was recommended for the use of carbon-hydrogen, nitro­
gen, halogen, and sulfur determinations (Steyermark, et al., 1949). The 
modified Micro method was used for the determination of nitrogen In the 
clot which Is the indirect measurement of the fibrinogen content of the 
clot. To form the clot, 2 ml of .85% saline, 0.1 ml of 1% calcium chlor 
ide and 0.5 ml citrated plasma (4% citrate) placed in a test tube and 
10 NIH units of thrombin (Topical, Parke-Davis) added and gently shook 
to mix the reaction mixture well. The mixture was incubated in 37°C 
water bath for 30 minutes. After 30 minutes of incubation the fibrino­
gen polymerized and fibrin clot formed.
The clot was winded with a glass rod and bolted on filter paper 
to take the moisture of the clot. The winded clot was put in Kjeldahl 
flask and washed with 0.85% saline twice in 30 minutes and decanded the 
wash solution (saline). To the clot 2 ml of digestion mixture was added 
and allowed the clot to digest in the digestion mixture for 24 hours. 
After 24 hours of digestion, the digested clot was placed on the flame in 
order to cook for 8 hours. After the cooking, 0.5 ml of superoxal was 
added and cooked additional 30 minutes.
Distillation; Digested clot was removed from the fire and 
cooled before distillation. In order to run a blank, 2.0 ml of digestion 
mixture was added to the funnel and rinsed with small amounts of triple 
distilled water. The stopcock was closed after the formation of bubbles 
in the reservoir. The 5 ml of Boric acid was placed in 50 ml of Erhlen- 
meyer flask and put on the end of the outlet tube. The gas was allowed
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to bubble through indicator until the flask was 2/3 full. The flask was 
removed and titrated with standardized acid (N/lOO HCl)• Reading-blank- 
X X Factor of acid-fibrinogen in mg%. In the Kjeldahl distillation appa­
ratus (Figure 17) changes were made in the conventional designs of the 
distillation flask and the condenser tube had to be lubricated with stop­
cock grease and held together with a suitable clamp, and a west-type 
condenser (Scientific Glass Apparatus Co., Inc., Bloomfield, N.J.).
Operation: With both stopcocks open, the sample was introduced
through the funnel and the curved tube into the inner chamber or distilla­
tion flask. The alkali (saturated NaOH) was added in like manner, dis­
placing the acid portion upward. Steam was generated with the stopcocks 
on both the sample inlet funnel and the drainage tube closed and the 
distillation was allowed to proceed.
Several methods of cleaning could be used. The following one 
had been found satisfactory, particularly when boiling chips were employed 
in the digestion: While steam was being generated and with both stopcocks
closed, the sample inlet funnel was filled with water and the tip of the 
condenser immersed in about 100 ml. of distilled water contained in a 
beaker. Steam generation was stopped, and the stopcock of the funnel was 
opened slowly, being closed before all the water had drained into the ap­
paratus. Reduced pressure caused the water to be sucked from the beaker 
into the apparatus, washing it. The stopcock in the drainage tube was 
opened to empty the liquid which had collected in the outer jacket, the 
steam generation was started again, and the procedure was repeated.
The inner portion of the Kjeldahl apparatus was heated by steam 
flowing through the system, in contrast to maintenance of the temperature
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FIGURE 17. Kjeldahl Distillation Apparatus: Changes
have been made on a conventional design of 
the distillation flask, and the condenser 
tube, they include a ball and socket joint 
connection.
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by a vacuum jacket. The steam entered through the vertical tube extend­
ing almost halfway up the outer jacket at the left, surrounded the distil­
lation flask proper (inner jacket), and passed into the small bent tube 
near the top right (above the sample tunnel inlet), and then downward 
through the bent portion of the tube at the lower end of the inner jacket 
and up into the center portion of the distillation flask. The two traps 
with T shaped tubes held back alkali spray.
Reagents for Kjeldahl method:
(1) Digestion Mixture:
600 ml. sulfuric acid (HgSO^)
200 ml. phosphoric acid (H^PO^)
8 gm. Cupric sulfate (CuSO^)
8 gm. Selenium dioxide (SeO^)
Acids were mixed and the mixture was divided into two sep­
arate containers. The CuSO^ was dissolved in one part and 
the SeOg in the other, let the solution settle for 24 hours 
then recombined.
(2) Boric Acid indicator (stored in dark bottle)
100 gm. Boric Acid
20 ml. 0.1% Bromcesol green in 95% ethanol 
10 ml. 0.1% methyl red solution in 95% ethanol 
Diluted with distilled water to 2000 ml. (this solution was 
supersaturated).
(3) Saturated NaOH.
(4) Standardized N/lOO HCl.
(5) Superoxal (30% HgOg: Merck and Co.)
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Results :
Fibrinogen values in the test population ranged 155 to 220 mg 
percent with a mean of 194 mg%. Fibrinogen values in the population (con­
trol ranged from 300 to 410 mg percent with the mean of 330 mg%. (Figure 
18.)
The t-tests were used as a test for significance between the 
rabbits eight week mean values of both the test and control populations.
The results of these tests were highly significant. By establishing the 
level of significance to be accepted at 0.05 or 95 percent the t-test 
of the eight weeks mean values of both the exposed and the control pop­
ulations as groups gave a level of significance of P > 0.001, a highly 
significant difference.
3.14 Rapid Sensitive Method for Measuring Fibrin/Fibrinogen 
Split Products in Rabbit Serum;
The technique of Merskey and co-workers has been modified by 
using the reagents and method of reading hemagglutination patterns de­
vised by Wegmann and Smithies (Wegmann, et al., 1966). A method has 
emerged which can be completed within an hour after receipt of the serum 
sample. It is sensitive enough to detect minute amounts of fibrin split- 
products in 95% of normal serum.
Principle: Serially diluted samples of serum to be tested were
incubated with antifibrogen rabbit serum. If there were no fibrinogen 
split-products in the diluted test serum, the mixtures retain a full 
amount of fibrinogen antibody; the more split-products present in serum the 
less residual antibody was found in the Incubation mixture. After incu­














FIGURE 18. Fibrinogen concentrations in the plasma of 
exposed rabbits are reduced due to the par­
tial degradation of fibrinogen molecule.
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fibrinogen-coated, erythrocytes. The amount of split-products could be 
estimated from the dilution of serum which inhibited the agglutination of
the coated cells. The more residual antibody in serum mixtures the lower
the titer of inhibition of erythrocyte agglutination and, thus, the higher 
the titer of inhibition the higher the concentration of split-products in 
the test serum.
3.14.1 Preparation of Fibrinogen Coated Erythrocytes;
(1) Nine volumes of group 0 human blood were mixed with one volume
of 0.1 M sodium oxalate.
(2) The erythrocytes were separated by centrifugation and washed 
four times with 0.9% sodium chloride solution.
(3) Formalinization: To 1 volume of 3% formaldehyde in saline
(previously brought to pH 7.2 to 7.4 with sodium hydroxide). The cells 
were kept suspended with a magnetic stirer (slow speed) for 20 to 24 
hours at 37°C and then were washed three times with saline and stored
as a 20% suspension at 5°C in phosphate-citrate buffer (equal volumes of 
0.15 M phosphate buffer, pH 6.4, and 0.1 M sodium citrate containing 0.1% 
sodium azide). Such cells were stable for at least several months.
(4) Tanning: The 20% suspension of formalinized erythrocytes
is diluted 10-fold with phosphate-citrate buffer. Equal volumes of this 
2% cell suspension and 1:40,000 freshly prepared tannic acid in the same 
buffer were incubated for 1 hour at 56°C with gentle mixing every 20 
minutes. The tanned cells were washed three times with phosphate-citrate 
buffer.
(5) Fibrinogen coating of erythrocytes: A 4% suspension of for­
malinized, tanned erythrocytes in phosphate-citrate buffer was mixed with
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an equal volume of fresh, oxalated, normal, plasma which had been diluted 
250-fold in the same buffer. The mixture was incubated for 1 hour at 37°C 
with gentle mixing. The cells were washed three times in phosphate- 
citrate buffer and suspended, at 10% concentration, in a phosphate-citrate- 
albumin buffer (0.4 bovin serum albumin in the phosphate-citrate buffer). 
When stored at 5°C, this stock suspension was stable for at least 2 months. 
One milliliter of packed cells was sufficient for several hundred assays.
Test Serum; The rabbit's freshly drawn blood was mixed with 
soybean trypsin inhibitor (2 mg/2 ml of blood) (type I-S, Sigma Chemical 
Company) to prevent fibrinogenolysis after collection. The mixture 
was promptly inverted three times and then was allowed to clot at room 
temperature until retraction was evident. The serum was harvested after 
centrifugation and was stored, if need be, at 5°C (at which temperature 
was stable for several days) or at -20°C (at which the fibrinogen split- 
products remained unaltered indefinitely).
Antifibrinogen Rabbit Serum: This was obtained from Hyland
(Los Angeles) and was absorbed with 1/4 volume of erythrocytes at 5°C over­
night. The antifibrinogen serum was first serially diluted to deteirmine 
the highest dilution which will strongly agglutinate erythrocytes coated 
with fibrinogen. The technique described in the following paragraph was 
used. Antiserum was substituted for the rabbit's serum and then coated 
cells were added. The highest dilution of the antiserum yielding 4+ ag­
glutination was 1:40,000. This antiserum was used in the hemagglutina- 
tion-inhibition assay at one dilution less (1:20,000) than the highest 
dilution.
Assay Procedure: (1) The test serum was serially diluted. To
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every well of a type U microtiter plate was added 0.025 ml of phosphate- 
citrate- albumin buffer with a pipet dropper. Then, 0.025 ml of test serum 
was placed in the first well of each row (duplicates) with microdiluters. 
The serum and buffer were mixed by swirling the microdiluters 20 times.
The diluters were then transferred to the next wells of the rows, carrying 
along 0.025 ml of the mixture. Simultaneous dilutions of as many as eight 
rows could be carried out by placing the stems of the microdiluters against 
a glass rod covered by rubber tubing, to keep them evenly lined up during 
the transfer (Figure 19).
(2) Antifibrinogen serum diluted 1:20,000 was added (0.025 ml 
to each well) with a pipet dropper.
(3) The plate was vibrated for 60 seconds and then incubated at 
30°C for 10 minutes.
(A) The formalinized, tanned, fibrinogen-coated erythrocytes 
in 1:1250 suspension in phosphate-citrate-albumin buffer were added (0.025 
ml to each well) by a pipet dropper.
(5) The plate was again incubated for 10 minutes at 30°C.
(6) The plate was centrifuged at 1,500 rpm for 30 seconds. It 
was then placed almost vertically (80°) against a white-light viewbox.
(7) The button of cells in each well was observed closely for 5 
to 15 minutes for the developing pattern and was graded as 0 to 4+. A 
negative pattern (inhibition of agglutination) was represented by early 
migration of the cell button into a narrow line or tail. Grade 4+ agglu­
tination was represented by absence of tailing and persistence of agglu­
tinated cell button in its original rounded form. Grades 14-, 24-, and 34- 
rep resented intermediate stages between prominent tailing with a small
FIGURE 19. Typical result with microtitre plate from 
the inspection of the standard titration 
(row B) the sensitivity of the assay deter­
mined. (That is concentration of fibrino­
gen at the end point.)
The end-points of the samples were read in 
turn. Dilution factor at the end-point 
multiplied by the sensitivity of the assay 
to give the concentration of fibrinogen or 






residual button and only little tailing with a prominent button. The 
titer of inhibition was judged to be the highest dilution of test serum 
yielding less than a 3+ pattern.
(8) Fibrinogen control: The fibrinogen concentration in a
sample of normal plasma was evaluated by thrombin clottability (Morrison, 
1947). The plasma was then diluted in phosphate-citrate-albumin buffer 
to a fibrinogen concentration of 1 mg/100 ml (usually about 300-fold) 
and stored at -60°C. The diluted plasma was titrated simultaneously with 
every plate, exactly at the test serums.
(9) Nonspecific hemagglutination: Occasionally, the control well
containing test serum, buffer, and coated cells (but no antifibrinogen 
serum) will show agglutination, probably because of antibody in the test 
serum against formalinized cells. This nonspecific hemagglutination can 
be eliminated by absorbing 2 vol. of the test serum with 1 vol. of 
packed, formalinized, group 0, human erythrocytes for 10 minutes at 5°C.
Calculation and Presentation of Results: Although the split-
products of fibrinogen in serum were actually being detected, the value 
was expressed in terms of the whole fibrinogen standard in the control 
plasma. If the 1 mg/100 ml solution of fibrinogen (plasma) reaches an 
agglutination-inhibition end point at a dilution of 1:8, the concentra­
tion of fibrinogen in the plasma in the final well was 0.125 mg/100 ml 
or, more conveniently, 1.25 pg/ml. Any serum is then said to have fibrin­
ogen split-products equivalent to 1.25 yg of fibrinogen per milliliter 
at its own end point. The concentration of split-products is thus the 
reciprocal dilution of the serum multiplied by 1.25 and was expressed 
as pg/ml.
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residual button and only little tailing with a prominent button. The 
titer of inhibition was judged to be the highest dilution of test serum 
yielding less than a 3+ pattern.
(8) Fibrinogen control: The fibrinogen concentration in a
sample of normal plasma was evaluated by thrombin clottability (Morrison, 
1947). The plasma was then diluted in phosphate-citrate-albumin buffer 
to a fibrinogen concentration of 1 mg/100 ml (usually about 300-fold)
and stored at -oO°C. The diluted plasma was titrated simultaneously with 
every plate, exactly at the test serums.
(9) N o n s ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ n a t i o n :  Occasionally, the control well
containing bWÊNNNNNNNNNNNNNNNNNNNNNÊka^ed cells (but no antifibrinogen 
serum) because antibody the
serum nonspecific hemagglutination can
be elimlnaNRRRRRRRRRRRRRRRRRRRRRRRRRRNKa serum with
form^^^^^^^^^^^^ ^ ^ ^ ^ N ^ G ^ t h r o c y t e s 10 minutes
CalculaE^RRRRRRRRRRRRRRR^Ron of Results: Although the split-
products of fibrinogen in serum were actually being detected, the value 
was expressed in terms of the whole fibrinogen standard in the control 
plasma. If the 1 mg/100 ml solution of fibrinogen (plasma) reaches an 
agglutination-inhibition end point at a dilution of 1:8, the concentra­
tion of fibrinogen in the plasma in the final well was 0.125 mg/100 ml 
or, more conveniently, 1.25 pg/ml. Any serum is then said to have fibrin­
ogen split-products equivalent to 1.25 pg of fibrinogen per milliliter 
at its own end point. The concentration of split-products is thus the 
reciprocal dilution of the serum multiplied by 1.25 and was expressed 
as pg/ml.
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Fibrinogen Inhibition Fibrinogen Inhibition
Split-products ^ titer of _ in control ^ titer of
in test serum test serum plasma control
(FSP) plasma
or
Fibrin split-products (pg/ml) Fibrinogen in ^ Inhibition titer
in test serum = control plasma of control plasma
(FSP) Inhibition titer of test serum
Results : The results were summarized in Figure which compiles
the effect of CO on fibrinolytic activity. Increased fibrinolytic 
activity was induced in the animals that were exposed to CO within the 
wide range from 20 pg/ml to 80 pg/ml of fibrin degradation products.
From the Figure 20 it is clear that the fibrinolytic enzyme system was 
not exhausted after certain time period. These observations would pos­
sibly indicate that blood of exposed rabbits contains an amount of plas­
minogen activator sufficient to get up to 80 pg/ml fibrin/fibrinogen 
degradation products in serum.
3.15 Immunodiffusion Plate Technique for g^-Macroglobulin Test:
Serum proteins are of such a complex chemical nature that they 
have been difficult to identify or to differentiate by conventional 
chemical and electrophoretic techniques. By usual electrophoretic 
methods, serum proteins are classified into groups designated as albumin, 
Alpha^ globulins, alphag globulins, beta globulins, and gamma globulins.
A number of protein fractions present in serum are not readily distinguish­
able by electrophoresis, primarily because of similar or overlapping 
electrophoretic mobilities. Immunodiffusion techniques are specific 
for identification and quantitation of those proteins for which specific 
antibodies have been developed.
FIGURE 20. The concentration of split-products in the 
serum of exposed (test) rabbits increased 
due to the degradation of fibrinogen and/or 
fibrin.
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In the immunodiffusion plate the antigen placed in a well in anti- 
body-containing agar gel diffused into the agar and formed a precipitin 
ring. (See Figure 21) The diameter of this ring is directly related to 
the concentration of the antigen. Each immunodiffusion plate contained 
six wells, three wells for the three reference serums which were provided 
with the test kit. Thus, one plate was used to prepare a reference curve 
and simultaneously to test three unknown serum samples. Performance of 
the test and the determination of concentration of unknown sample were 
the same as explained before.
Results: The formation of precipitin rings were poor. No signi­
ficant difference of the precipitin rings between exposed and control 
group was found. There was no significant difference in the diameter 
of the precipitin rings and those with reduced but measurable areas gave 
the p-value > .50. Each sample was tested on three plates and applied 
in duplicate on each plate. Some variation in measurement was found 
between samples. The precipitin ring areas were calculated by DxD.
3.16 Quantitative alpha-l-antitrypsin test:
Alpha-1-Antitrypsin (a,AT), the major protease inhibitor of plasma 
(Briscoe, et al., 1966a; Miesch, et al., 1971b) is a polymorphic system of 
proteins which may be identified in a series of zones between orosomucoid 
and albumin when plasma is subjected to discontinuous starch gel electro­
phoresis at pH 4.5 (Kueppers, et al., 1966a; Fagerhol, et al., 1967b).
The abbreviation Pi (protease inhibitor) has been suggested for this com­
plex protein system, and seven co-dominant alleles were proposed to gene­
tically explain the system (Fagerhol, at al., 1967). Since a^AT is only 
one of several serum protease inhibitors, all of which may vary widely
\n\J1
FIGURE 21 The amount of immune precipitate formed 
is dependent upon the quantity of a, AT 
present in the test sample. There is 
no significant difference between the 
test and the control groups. From 1 to 3 
control (non-exposed). From 4 to 6 Ex­
posed, test group's samples applied.
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in concentration, immunological assays are more specific than enzymatic 
assays (Tarkoff, et al., 1968).
The serum â ÂT was determined by single radial immunodiffusion. 
Monospecific antiserum is incorporated within a buffered agar medium in 
plate and wells of exacting dimension were removed to receive the test 
sample. The buffered agar used in the plate media in order to allow free 
diffusion of serum protein while the monospecific antiserum restricts the 
diffusion of the a^AT by immune precipitation. The amount of immune pre­
cipitate formed is dependent upon the quantity of a^AT present in the 
test sample. The antiserum concentration is carefully controlled so that 
the size of the precipitin ring formed bears a linear relationship to 
the concentration of the specific protein after incubation for 24 hours
at room temperature. The reference curve is prepared by plotting the
ring diameters of the three reference sera on semi-logarithmic paper.
The concentration of a^AT is determined by comparing the ring diameter 
of the test sample to the reference curve. (Figure 22)
Results: Statistical analysis did not reveal any significant
differences between the exposed and the control rabbit serums. Figure 
gives the comparative range of the size of the precipitin rings between 
exposed group and the control. There was no significant change in the
size of the ring (p value of > 0.25).
3.17 Histological Studies: Differentiation of various tissue
components :
Staining procedure:
(1) Deparaffinized and hydrated with water.
(2) The mercuric chloride crystals removed with iodine and
FIGURE 22. Immuno-Plate (Reference rabbit serum curve) 
for antitrypsin.
a. Horizontal scale, the precipitin ring dia­
meters of three reference serums were plotted.
b. The concentrations of the corresponding ref­












cleaned with sodium thiosulphate.
(3) The slides were immersed in Harris' hematoxylin for 15 
minutes then rinsed with tap water.
(4) Differentiated in acid alcohol with five to eight quick 
dips. The differentiation was checked by microscope.
(5) Washed in tap water very briefly.
(Ô) Dipped in ammonia water or lithium carbonate water until 
the sections were bright blue.
(7) Washed in tap water for 15 minutes.
(8) Stained with eosin for 15 seconds to 2 minutes.
(9) Dehydrated in 95% and absolute alcohol until excess eosin 
was removed (in order to be sure checked under microscope).
(10) Absolute alcohol, two changes for 3 minutes each.
(11) Xylene, two changes of 2 minutes each.
(12) Mount in permount of Histoclad.
3.17.1 Azocarmine 6 Solution
Azocarmine G 1 to 1.5 gm.
Distilled water 200.0 ml
The reaction mixture was brought to a boil and filtered through
coarse filter paper in paraffin oven at 50°C, so that the fine particles
of dye would pass through. When the mixture cooled 2 ml of glacial
acetic acid was added and refrigerated. It was filtered before use.
3.17.2 Aniline-Alcohol Solution
Aniline oil 1 ml.
Alcohol, 95%, ethyl 100 ml.
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1% Glacial Acetic Alcohol
Glacial acetic acid 1 ml.
Alcohol, 95%, ethyl 100 ml.
5% Phosphotungstic Acid Solution
Phosphotungstic acid 5 gm.
Distilled water 100 ml.
Stock Aniline Blue Solution
Aniline blue, water
soluble 0.5 gm.
Orange G 2.0 gm.
Distilled water 100.0 ml.
Glacial acetic acid 8.0 ml.
Working Aniline Blue Solution
Aniline blue stock
solution 1 part
Distilled water 2 parts
Staining Procedure:
(1) Deparaffinize sections by passing through xylene, absolute 
and 95% alcohols down to water and removed the mercuric 
chlorides with iodine.
(2) Rinsed with distilled water.
(3) Stained in azocarmine G solution in a covered dish in the 
paraffin oven at 58°C for 15 to 20 minutes. Allowed to 
cool for 5 minutes at room temperature.
(4) Rinsed in distilled water.
(5) Differentiated in the aniline-alcohol solution until cytoplasm 
and connective tissue were pale pink and nuclei stood out 
sharply. Control differentiation by rinsing slide in 1%
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glacial acetic alcohol and checked with microscope.
(6) Mordant in 5% phosphotungstic acid solution until the connec­
tive tissue was completely decolorized 15 minutes to 1 hour. 
Checked with microscope at 15-minute intervals.
(7) Rinsed quickly in distilled water.
(8) Counterstained for 5 to 30 minutes in the working aniline blue 
solution until the finest connective tissue fibers were sharply 
stained.
(9) Examined from time to time with microscope.
(10) Rinsed in distilled water.
(11) Dehydrated quickly through 95% alcohol, two changes of 
absolute alcohol.
(12) Cleared with two or three changes of xylene, and mounted
•kin permount.
Results :
Microscopic findings in myocardial tissues were as follows: the
capillaries are extended filled with red blood cells which reveal clump­
ing. In some areas, there are slight extra-capillary accumulation of the 
red blood cells. In other areas, the arterial seems to have a thickened 
wall, and initiation of infraction is seen, in the myocardial tissues of 
exposed rabbits. Hardening of arteries and deposits of fatty material, 
chiefly cholesterol within the inner walls of arteries were seen (Figure 
23a,b,c).
3.18 Pilot Study:
In order to make sure that the elevated fibrinolytic activity
Pathological Technique Philadelphia: Mallory, F. B., p. 154
(1938).
FIGURE 23. Microscopic studies show major 
changes in myocardial tissues 
and arteries (vessel walls).
a) Changes in myocardial tissues
b) Hardening of arteries




was due to the plasminogen activator that was released from the endothelial 
cells of tlie vessel walls, a tiiird group of 6 rabbits were maintained under 
the same environmental condition in chambers. This time, concentration 
of the CO was increased to 300 ppm/8 hrs. for 5 days a week. A group of 
3 rabbits were placed in one chamber and another group of 3 rabbits were 
placed in the other chamber. Both groups were then given the same concen-; 
tration of CO (300 ppm/8 hrs) for 4 weeks (Figure 24). Concurrently a group 
of three rabbits were given epsllon-aminocaproic acid, (EACA, 200 mg/Kg) 
a known inhibitor of fibrinolysis (through inhibition of the activation 
of plasminogen). The clots from these animals were visibly different 
(Figure 25) and fibrin plates showed no lysis (Figure 26) when compared 
to the blood of the three rabbits receiving 300 ppm CO without EACA.
These findings clearly demonstrated that the enhanced fibrinolytic acti­
vity was due to the damage of the endothelial cells resulting in a leak­
age of the "tissue" activator into the circulation.
Blood samples were drawn as described before twice a week for 
hemoglobin, carboxyhemoglobin, o x y h e m o g l o b  i n and blood fi­
brinolytic activity which was measured by whole blood clot lysis, a 
modified Freanley technique, euglobulin lysis, fibrin plate, caseinolytic 
assay, fibrinolysis serum fibrin/fibrinogen degradation products. All 
test results, from this pilot study are shown in Figure 27. After two 
weeks of exposure, the blood fibrinolytic activity was enhanced in the 
group of 3 rabbits receiving 300 ppm CO/8 hrs for 5 days per week without 
EACA.
The group of 3 rabbits that received (EACA, 200 mg/Kg with 300 
ppm/8 hrs for 5 days per week did not show any fibrinolytic activity in
FIGURE 24. Comparative distribution patterns of 0„, 
Hb, and COHb in rabbits that were receiv­
ing 300 ppm CO 8 hr/day for four weeks 
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FIGURE 25. Whole blood lysis time: The whole blood from rabbits
that were exposed to 300 ppm CO with e-aminocaproic 
acid did not show any sign of lysis after one hour of 
incubation at 37°C water bath (test tubes from 1 to 3). 
The whole blood clot of rabbits that were exposed to 
300 ppm CO without EACA, started to lyse after 20 min. 
of incubation at 37°C water bath.
149
EL 1 ' - « B
a-:?.
FIGURE 26. Fibrin Plate (Hyland): Plasma samples of rabbits that
were exposed to 300 ppm CO with EACA (200 mg/kg) did 
not show any clear lysis zone on the fibrin plate after 
incubation at 37^C overnight (wells from 1 to 3). The 
plasma samples of rabbits that were exposed to 300 ppm 
CO without EACA (200 mg/kg) did show clear lysis zone 
areas on fibrin plate (wells from 4 to 6).
151
FIGURE 27. Shows changes in major parameters of blood of 
exposed rabbit (300 ppm CO without EACA). The 
rabbits exposed to 300 ppm CO without EACA show 
increase in fibrinolytic activity in all para­
meters. The rabbits that exposed to 300 ppm 
CO with EACA do not show elevation of fibrin­
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FIGURE 28. Immunoelectrophoresis of urokinases and concentrated 
urine: Well A is filled with 2 pi of concentrated
urine collected from rabbits, well B is filled with 
1 pi urokinase (Calbiochem) 100 OTA units/ml, migra­
tion proceeded for 45 min. at 250 volts; the troughs 





all parameters. These findings were clearly demonstrated that the stimu­
lus of release of fibrinolytic (plasmin) activating substances under the 
influence of environmental stimulus such a s CO is a pathophysiological 
and physico-chemical reaction which deserves further exploration. The 
recovery of "tissue" or endothelial activator offers a unique opportunity 
to study the molecular structure of this enzyme protein and metabolic 
mechanisms controlling its synthesis, release and degradation.
CHAPTER IV
DISCUSSION AND SUMMARY
Experiments were performed to demonstrate the effect of chronic 
low level carbon monoxide exposure in rabbits on blood fibrinolytic ac­
tivities.
Formation of fibrin is an important stage in hemostasis, throm­
bosis and tissue repair because the fibrin formed solidifies the hemo­
static platelet plug and provides a matrix for the formation of repara­
tive connective tissue with fibroblastic proliferation and growth of 
capillaries. Ultimately, the fibrin has to be removed, mainly by the 
process fibrinolysis, in order to restore normal conditions. Fibrin­
olysis is caused by the blood proteinase, plasmin. Plasmin (fibrin- 
olysin) is formed from a precursor, plasminogen (profibrinolysin), pre­
sent in blood plasma. Plasminogen is transformed to plasmin by a variety 
of activators (see Figure 1). Inhibitors regulate the activation of 
plasminogen as well as the effect of plasmin. In the living organism, 
a dynamic equilibrium, or hemostatic balance, exists between fibrin 
formation and resolution (see Figure 1). Disturbances in ̂ tAs balance 
may lead to impaired or to excessive fibrin formation and,\consequently, 
to impaired hemostasis or pathological tissue repair. The involvement 
of the mechanisms of blood coagulation and fibrinolysis in the regulation
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of tissue repair signifies them as fundamental physiological pro­
cesses, important not only in hemorrhagic disorders and in thrombo­
embolic disease but playing a role in a multitude of pathological 
conditions.
The fibrinolytic activity of tissue is mainly caused by 
plasminogen activator. Plasminogen activator is present in normal 
blood in only small amounts. Most likely it is released from Llie 
vascular endothelium. The fibrinolytic system controls and regu­
lates the enzymatic degradation of both circulating fibrinogen and 
intra- and extravascular deposits of fibrin.
The extent and ultimate fate of a fibrin deposit depends on 
the degree of injury and on the availability of components of coag­
ulation and fibrinolysis and their inhibitors.
An enhancement of blood fibrinolytic activity in the blood 
of CO exposed individuals had been previously suggested by Sairo 
et al., (1968).
In order to understand the effect of CO on fibrinolytic ac­
tivity in depth using the most advanced techniques and modifying the 
traditional ones to measure the fibrinolytic activity in highest 
sensitivity in rabbit blood that was exposed to low-level CO. Tra­
ditional studies of CO toxicology have emphasized the dramatic ef­
fects of heavy exposure, remarkably little information is available 
about the consequences of exposure to the low concentrations found 
in the polluted community air. The concentration of CO chosen 
for this study was a level to which animals could be exposed
without manifesting an acute CO toxicity and a level below that normally 
encountered by man in his environment (200-300 ppm of CO inhaled in cig­
arette smoke) and present for brief periods in confined areas of automo­
bile congestion.
A consistent pattern of acquired change in fibrinolytic activity 
was observed in the CO exposed animals for the various time intervals, 
each of which tend to confirm the other. There is little experimental 
evidence available in the literature to support the claims incriminating 
CO as a distinct health hazard at the lower levels of exposure. The re­
sults of this study suggest that low levels of CO may play an important 
role in fibrinolytic activity and coronary thrombosis. The effects of 
CO exposure as reported herein, hopefully, will serve to stimulate fur­
ther investigation in this area.
The possibility that CO exposure influence the hemorrhagic dis­
orders and the thromboembolic disease in man. This study of the blood 
fibrinolytic activity under the stimulus of CO exposure will help the 
future investigators to understand the relation between low level CO 
exposure and blood fibrinolytic enzyme systems. Under the conditions 
of these experiments CO did not alter the effect of a 2  macroglobulin. 
This is very important information for the immunological studies of the 
blood diseases. In all these studies and statistical analyses, no change 
was revealed in the quantity of hemoglobin.
The results of this study shows that platelet quantity changes 
in the low level CO exposure. This is a significant change in the blood 
of animals. Platelet counts were performed using plasma from animals
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that were exposed to CO and received epsilon amino caproic acid (EACA) 
varied etiology from normal subjects and with those exposed to only CO 
without EACA. Studies of the effects of CO on blood platelets are con­
tributing to the yet fragmentary understanding of the mechanism of re­
duction of platelet in the circulation. The number of platelets in 
blood of CO exposed animal diseases after the depletion of oxygenated 
hemoglobin begins after about a week of moderate exposure. These re­
sults demonstrate that the number of circulating platelets has a reg­
ulatory effect on fibrinolytic activity. Moreover, the number of mega- 
karyocytic mitotic figures begins to increase rapidly about 24 hours 
after platelet depletion, suggesting an influx of DNA-replicating cells 
into the recognizable population. It is difficult to state with cer­
tainty from the present data here that the CO also may cause destruction 
of some platelets during their maturation process, because data derived 
from peripher platelet counts may not have precise quantitative value, 
a marrow study may be needed to understand the cause of platelet de­
struction.
The low platelet count seen in CO exposed animal blood may be 
the result of both increased platelet destruction and/or relatively 
reduced platelet production. Platelet consumption occurs either as 
part of a process of intravascular coagulation (McKay, 1968) or by the 
effect of an abnormal vascular surface which is independent of coagula­
tion (Barker, 1970). In the process of fibrin formation, the clotting 
factors fibrinogen, prothrombin, V, VIII, and XIII are consumed, along 
with platelets. Widespread vascular injury, i.e., vasculitis, produces 
thrombocytopenia due to the direct consumption of platelets by the
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damaged endothelium, without associated clotting factor depletion. Endo­
thelial damage is considered the etiology of the frequent thrombocytopenia 
and the less often observed intravascular coagulation.
Platelet consumption is the most likely explanation for the slightly 
reduced platelet survival observed in atherosclerosis (Murphy and Mustard, 
1962) arterial hypertension, hypoxia, thrombo-embolic disease (O'Neill 
and Fikkin 1964). Reduced life-span of platelets has been observed in 
gout (Murphy , ejt al, 1963) acute fibril disorders (Abrahamsen, 1968) 
and in smokers (Murphy and Mustard, 1963). This brief information about 
the platelet reduction in blood of CO exposed animals will help the 
scientists in this expanding field which has developed in the areas of 
nuclear medicine, cytology, and statistics. Radioisotope techniques were 
the first to appear, providing in the late fifties platelet labels whose 
binding characteristics have been thoroughly studied and perfected in the 
following twelve years. The best of labels enable determination of plate­
let life-span, pooling and production. The use of radioactive iron to mea­
sure megakaryocytes was another recent and fruitful application of radio­
isotopes to platelet kinetics.
It has been observed that rabbits exposed to low levels of CO 
were endowed with greater capacity to increase fibrinogen degradation 
products in the circulating blood.
The t-test was used as a test for significance between the eight- 
week mean values of both the exposed and control rabbits' serum. The 
results of these tests were highly significant. Rabbits exposed to low 
levels of CO have high level of fibrinogen/fibrin degradation products.
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The results of the studies associated with decreased fibrinogen 
concentration indicated that CO, under the experimental conditions em­
ployed, served to enhance the release of plasminogen activator from the 
vessel endothelial into the circulation. The biological activator of 
plasminogen is a proteolytic enzyme which is capable of hydrolyzing argi­
nine and/or lysine bonds. The type derived from vascular cells is soluble 
and presumably diffuses into the circulation in response to vasoactive 
stimuli caused by CO toxication. The release plasminogen activator acts 
on circulating plasminogen and converts it to plasmin which is an endo- 
peptidase that hydrolyzes susceptible arginine and lysine bonds of fibrin­
ogen or fibrin at a natural pH, producing smaller molecular weight of 
fibrinogen degradation products. Degradation products of fibrinogen and 
fibrin appear in the systemic circulation as a result of this enzymatic 
digestion of circulating fibrinogen or fibrin clot dissolution. These 
derivatives have striking anticoagulant effects and, when present in suffi­
cient concentrations, contribute to the severe hemorrhagic disturbances 
seen in the myocardial tissues of exposed rabbits under the microscope.
There is much information available concerning the effect of 
fibrin split-products upon coagulation systems. The recent report of 
Barnhart and her associate of the increased platelet aggregation and ad­
hesiveness caused by fibrin split-products also gives an excellent re­
view of some other aspects of split-products on the clotting system.
As previously described, decreased plasminogen activator activity 
in the blood was demonstrated in rabbits of exposed to 300 ppm CO with 
EACA. Decrease and total absence of plasminogen activator activity in
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these animals clearly explained the possibility of fibrinolytic enzymes 
being released from the vascular wall. Kwaan and McFadzean showed in­
creased fibrinolytic activity in blood withdrawn from an ischemic arm.
Because of the degradation process in the blood of exposed 
rabbits, the fibrinogen constant is highly reduced.
Urine samples collected from both groups and checked for fibrin­
olytic activity on fibrin plate and caseinolytic assay showed nu dif­
ference in fibrinolytic activity in both groups of exposed and non­
exposed (control). Both groups showed fibrinolytic activity on fibrin 
plate and caseinolytic assay due to the urokinase presence in urine.
The t-tests were used as a test for significance between the 
mean values of both the test and control groups. This statistical analy­
sis did not reveal any significant difference in fibrinolytic activity 
between the two groups, the test and the control groups. The fibrinoly­
tic activity is enhanced in the blood of exposed rabbits and the statis­
tical analysis revealed a highly significant difference in fibrinolytic 
activity between the test and the control groups. These results demon­
strate that plasminogen activator is released from the vessel walls of 
endothelial tissues which is not related to the urokinase activity. 
Plasminogen activity is enhanced in the blood of chronic low level CO 
exposed rabbits because of the possible vascular injury, i.e., vasculi­
tis and/or stimulus of the endothelial cells causing the release of 
plasminogen activator into the circulation.
Several investigators have suggested that the kidney is the 
source of circulating plasminogen activator (Buluk, et al., 1962a;
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Holemans, £t , 1965b; Menon, et al., 1968c) and urokinase (Charlton, 
1966a; Nowak, 1966b; Vreeken, , 1966c) as well. As for urokinase,
the alternative suggestion that this activator is filtrated from circu­
lating blood into the urine has also been reported (Kaulla, e^ al.,
1958a; Smymiotis, £t al., 1959b; Riggenbach, e^ ̂ . , 1961c)
In this present investigation, a significant increase of fibrin­
olytic activity in blood of CO exposed animals but no change in urokinase 
excretion was demonstrated. The statistical analysis did not reveal any 
significant difference in urokinase excretion between the test and con­
trol groups. From the results of this investigation it appears to be at 
variance with the previous assumption that the kidneys are a main source 
of circulating plasminogen activator. The different interpretations can 
be reconciled if one assumes that the kidney, instead of being a site of 
plasminogen activator synthesis as such, is a main organ able to synthe­
size a "humoral factor" which in turn stimulates the release of plasmino­
gen activator from organ or organs where it is really synthesized.
The question arose whether a high level of non-protein-nitrogen 
will interfere with the fibrinolytic enzyme system. Norman (1957) had 
demonstrated that only a urea concentration higher than 1.5 M could in­
hibit plasmin proteolytic activity on a casein substrate in the test tube. 
He also demonstrated that normal urine which contains 0.3 M urea induced 
lysis areas on unheated fibrin plates.
Some investigators suggested that the kidney would excrete acti­
vator, partly into the blood stream, and partly into the urine as uro­
kinase. The decrease of both circulating fibrinolytic activity and
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urokinase excretion seen in renal disease, would then be easier to under­
stand. However, it has turned out that the relationship of kidney to 
that fibrinolytic system is not that simple. The observations on fibrin­
olytic system in exposed and non-exposed rabbits blood as described 
earlier, were obviously not in accord with the concept of the kidney as 
the main source for the circulating plasminogen activator.
A basic query permeates all these considerations, namely whether
or not urokinase is filtered from circulating blood. Statistical analy­
sis did not reveal any relationship between blood fibrinolytic activity 
and urokinase excretion in normals as reported in the literature (Charlton, 
1966a; Nowak, e^ ̂ . , 1966b) and found in this present investigation as 
well. This non-existence of this relationship cannot be used as evidence 
against the assumption that urokinase is filtrate from the circulating 
blood. First, urokinase might— at least theoretically— be present in 
the blood as an activator-antiactivator complex, or adsorbed to blood 
corpuscles such as erythrocytes. Second, the question arises whether a 
single determination of euglobulin lysis time and the daily urokinase 
excretion are comparable. Fearnley (1965) had shown that there is a di­
urnal variation in the fibrinolytic activity of normal persons.
If urokinase is derived from the circulating blood, indeed, by 
what mechanisms will it be excreted through the kidney? The molecular 
weight of urokinase is 54,000, smaller than albumin (69,000). It has 
been shown that the pore radius of the glomerular membrane of the kidney 
is in range between 18 and 50 and serum albumin has a "dimension"
of 18 by 75 A° (Norman, 1957). Serum albumin is found in the glomerular
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filtrate and is partially reabsorbed by the renal tubule. Consequently, 
it is possible that urokinase can be filtered through the glomerular base­
ment membrane. Another possibility is that tubular excretion of urokinase 
from blood into urine. Finally, urokinase might be formed in the kidney. 
If urokinase is a product of the kidney, one has to explain the demon­
strable lag period in those transplanted patients who pre-operatively had 
no urokinase excretion.
Euglobulin lysis time test, used for the check of fibrinolytic 
activity of the blood of test and control groups. This test is based 
on the precipitation of fibrinogen and the fibrinolytically active com­
ponents of plasma by acidification and lowering ionic concentration. The 
test has also been modified for use with whole blood instead of plasma.
Tlie advantages are that it is relatively simple and can be performed 
without elaborate equipment. The t-tests were used for the test for 
significance between the eight week mean values of both the test and con­
trol populations. The results of these test presented (Figure 6 ). By 
establishing the level of significance to be accepted at 0.05 or 95 per 
cent, using the eight week mean values of both the test and control pop­
ulation as groups gave a level of significance P > 0.001, a highly sig­
nificant. The third group of rabbits (pilot study) receiving (EACA 
200 mg/kg) with 300 ppm CO did not show any significant increase in fi­
brinolytic activity. The other group of 3 rabbits were exposed to 300 
opm CO without EACA showed enhanced fibrinolytic activity. There is a 
visible difference in the blood of rabbits exposed 300 ppm CO and the 
rabbits received EACA with 300 ppm. Whole blood clot of both groups
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show a visible difference in their solubility. The clot of whole blood 
from rabbits that received 300 ppm CO without EACA start lysis after a 
half-hour incubation at 37°C water bath and in one hour period, 70-80 per 
cent of the clot lysed. The clot of whole blood from rabbits that re­
ceived 300 ppm with EACA did not show any sign of lysis (Figure 23).
Determination of alpha-l-antitrypsin concentrations of both the 
test and the control groups plasma showed no significant differences 
between the exposed rabbits’ plasma and the controls'. The t-tests were 
used as a test for significance between the eight-week mean values of 
both the test and control populations at the level of significance to 
be accepted at 0.05 or 95 per cent, analysis did not reveal any signifi­
cant difference between the test and control groups.
The Og-macroglobulin test is used to determine the quantity of 0 2 - 
macroglobulin in the blood of test and control rabbits. Statistical analy­
sis did not reveal any significant difference between the test and the 
control population. From these last two observations (alpha-l-antitrypsin 
and Og-macroglobulin tests) it is clear that increasing plasma plasminogen 
activator in the blood of CO exposed rabbits does not appear to be affected 
by these inhibitor proteins. Relationship between plasminogen activator 
and these inhibitor proteins are known to a certain extent, but it is 
not clear that the increased plasminogen activator induces the release 
or synthesis of these proteins. There were no experiments carried out 
during this present investigation to probe into the possible mechanism 
of removal of the plasminogen activator from the circulation. Several 
investigators have suggested that the liver is clearing the plasminogen
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activator from the circulation= There is no doubt that the liver clears 
plasminogen activator, but, the exact mechanism by which this is achieved 
needs much further investigation. It would not be surprising if future 
studies should show that the liver is capable of the triple functions of 
excretion plasminogen activator with the bile, abolishing plasminogen 
activator of hepatic blood flow and being able to control the release 
of plasminogen activator from organs or tissues as well.
The fibrin plate method assay used for the measurement of plasma 
fibrinolytic activity of the exposed and control groups. A reference 
standard curve was constructed and using the reference curve the activity 
was converted to CTA unit of urokinase per ml.
The fibrin plate (Hyland) showed a significant difference between 
the test and the control groups. There were visible (Figure 23) and 
obvious differences between exposed rabbit plasma lysis zone and control 
rabbit plasma lysis zone. Essentially, control rabbits' (non-exposed) 
plasma did not show any lysis on the fibrin plate after 16 hours of 
incubation at 37°C.
Modified Micro-Kjeldahl Method used for fibrinogen determination 
in the plasma of the rabbits exposed to CO and non-exposed (control).
The t-tests were used as a test for significance between the eight-week 
mean values of both the exposed and control rabbits' plasma. The re­
sult of these tests were highly significant. Rabbits exposed to CO 
have lower concentration of fibrinogen. The clottability test for fi­
brinogen gave the similar results as Kjeldahl.
Caseinolytic assay on exposed and nonexposed rabbit plasma: A
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typical result from caseinolytic assay shown in (Figure 23). Increased 
caseinolytic activity is observed from the plasma samples of exposed 
rabbits. The activation reaction followed zero order kinetics for the 
first 20 minutes with the rate of plasmin generated being roughly pro­
portional to the amount of activator present. EACA (20mM) in the activa­
tion mixture completely suppressed the plasminogen activation by the 
exposed rabbit plasma. At the zero time, small amounts of activations 
were found and were probably due to the plasmin contamination of the 
plasminogen preparation. This blank value was subtracted. The evolving 
plasmin activity, therefore, is solely the result of plasmin generated 
during the incubation period. Here again, the reaction followed zero 
order kinetics for the initial period and the initial rate of plasmin 
generation was proportional to the activator concentration.
Microscopic findings in myocardial tissues were as follows: the
capillaries are extended filled with red blood cells which reveal clump­
ing. In some areas, there are slight extra-capillary accumulation of the 
red blood cells. In other areas, the arterial seems to have a thickened 
wall, and initiation of infraction is seen, in the myocardial tissues of 
exposed rabbits. Hardening of arteries and deposits of fatty material, 
chiefly cholesterol within the inner walls of arteries were seen (Figure 
23 a,b,c.)
Summary and Conclusions
Traditional studies of CO poisoning have emphasized the dramatic 
effect of heavy exposure, but little information is available about the 
low level chronic exposure of CO found in community air. The small amounts
170
of carboxyhemoglobin in the blood has so far not been regarded as having 
a significantly harmful effect. It is hoped that the results of this 
study will convince that the previous assumption is wrong.
In man, intermittent exposure to carbon monoxide, rather than 
to nicotine, due to tobacco smoking may be regarded as the real cause 
of much higher risk for smokers to develop arterial diseases compared with 
non-smokers.
The chronic low level CO exposure causes deposition of fatty ma­
terial on the endothelial of the vessel walls that causes tissue damage 
because of lack of oxygen. This tissue damage results, often producing 
death by heart attack, strokes, etcetera. The medium-sized arteries 
supplying the heart, brain, extremities, and other organis with blood 
becomes increasingly less able to furnish enough blood to these organs 
because of decreased size of the lumen, or inner diameter of the blood 
vessel.
Increase in permeability of the endothelium tissues induced by 
CO or hypoxia leads to the formation of subendothelial edema, lipid ac­
cumulation, and other arterial injuries seen in experimental animals.
This agrees well with the filtration theory for the pathogenesis of 
atherosclerosis and emphasizes the importance of this theory. The mo­
lecular process involved in the permeability change should be identified 
and a possible relation to a hypothetical oxygen-dependent control sys­
tem for endothelial permeability should be evaluated.
Change in endothelial permeability is not only causing increased 
fibrinolytic activity but possibly increased permeability of other signi-
171
fleant enzymes in excess into the circulation.
Increasing fibrinolytic activity may cause a great change in 
viscosity of the blood flow which is very important factor in coronary 
heart diseases.
Increase in carboxyhemoglobin may change the synthesis of several 
enzymes and clotting factors. A drop in the level of the clotting factors 
II, V, VII, and IX (except fibrinogen and X) in the liver certainly can 
contribute to the bleeding diathesis in the chronic CO exposed animals.
COHb levels measured after smoking jnay indicate the risk for 
the smoker in the work place or in the community might help to discourage 
smoking.
The result of this investigation suggests that the CO concentra­
tions in occupational exposure to CO concentration not greater than 20 
ppm was determined as a time-weighted average (TWA) exposure for an 8-hr 
per day.
In evaluating the exposure of employees who have coronary heart 
diseases with angina pectoris to CO sufficient to produce a COHb level 
of 5 per cent, while a small additional decrease in Og saturation of the 
blood brought about by mild exercise might be feasible, "the degree of 
blood oxygen desaturation demanded with 10 percent COHb loading is rather 
'severe'." The recommended TWA standard of 35 ppm CO is based on a COHb 
level of 5 percent, which is the amount COHb that an employee engaged in 
sedentary activity would be expected to approach in eight hours during 
continuous exposure. The recommended standard does not take into con­
sideration the smoking habits of the worker since the level of COHb is
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chronic cigarette smokers has generally been found to be in 4 to 7 percent 
range prior to CO exposure. The recommended standard is based on the 
utilization of the Cobuim equation to predict the mean COHb level of non­
smoking employees exposed to a known TWA concentration of CO for an 
eight-hour workday. The applicability of the equation for this purpose 
has been validated by a study of Peterson and Stewart in which the COHb 
levels of sedentary young males exposed to known TWA concentrations of 
CO for known periods of time were predicted by the equation.
The investigations leading to the results presented here have 
proved fascinating and challenging to us, not only because of their im­
portant practical aspects concerning a disease which today dominates 
the mortality statistics in this part of the world.
Research in the coming years will show if new developments and 
new ideas of importance for the theory and practice of environmental 
control.
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